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ABSTRACT 
Background and objectives: 
        A study of incidence of Acute Kidney Injury, Clinical profile 
and Investigations of patients admitted with snake bite and systemic  
envenomation and an analysis of the outcome of these patients in 
response to multiple factors. The study also determines if there is any 
age or sex predilection for the severity of envenomation.  
Materials and methods:   
100 cases admitted at Government Mohan Kumaramangalam 
Medical college Hospital, S a l e m ,  during the period April 2015 to 
March 2016, with clinical evidence of snake bite envenomation were 
included in the study after taking into account the inclusion and 
exclusion criteria. Out of the 100 cases 56 were males and 44 were 
females. All the 100 cases were treated for snake envenomation and 
their laboratory work up and follow up data were collected and 
studied.  
Results:  
44% of Snake bite victims have developed Acute Kidney Injury. 
Delay in admission was strongly correlated with development of 
Severe AKI (P<0.0005). Victims with co-morbidities are more prone 
20 
 
to develop AKI and Complications. Most of the patients with AKI 
(93%) had Cellulitis and Lymphadenopathy (P<0.05). AKI is 
uncommon in Patients without coagulopathy. Thrombocytopenia and 
Albuminuria can be taken as early markers of Severe Envenomation 
(P<0.0005) and Acute Kidney Injury (P<0.0005) respectively. 80% 
of patients were required conservative management only. 90% of 
AKI Patients recovered completely (P<0.0005). Only 6 patients of 
Stage 3 AKIN (24%) become dialysis dependent. 4 patients in 
AKIN3 group (16%) died due to complications of AKI (P<0.0005). 
People who were initiated on prompt medical therapy earlier and 
follow up showed signs of early recovery and favorable prognosis. 
This was also corroborated with the laboratory work up results of 
these patients. 
Interpretation and Conclusion:  
     Early admission to the hospital and early administration of 
Inj.ASV with adequate supportive therapy is important to prevent 
development severe Acute Kidney Injury and its complications. The 
morbidity and mortality is high if severe cellulitis is associated with 
prolonged coagulopathy . 
Key Words: Snake Bite, ASV, Acute Kidney Injury, 
Hemotoxicity. 
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INTRODUCTION 
            Snake bite envenomation is a significant cause of mortality and 
morbidity in tropical as well as subtropical countries like Indian 
subcontinent. Envenoming by poisonous snakes is an occupational hazard 
commonly occurs in farmers and people living in rural and forest 
areas.The habit of moving out about bare footed in these areas contribute 
to its higher incidence. It is a leading cause in premature death in rural 
India1. 
It causes two types of toxicity, hemotoxicity and neurotoxicity depends 
upon the snake which bites. Acute renal failure can occur with the bite of 
any venomous snake.It is more common with snakes of the viperine 
species. The worldwide published statistics on the incidence of Acute 
Kidney Injury (AKI) following venomous snake bite in developing 
countries like India are inadequate as a proportion of the victims resorting 
to traditional means of therapy often resulting in deaths5. 
      The Annual global mortality from snake bites is estimated at around 
94000 Per year with around 15000 deaths occurring per year in India 
alone4. 
      The incidence of Acute Renal Injury in India is 20-32% following 
viper bite.There is wide spread discrepancy with the data available on the 
Incidence of Acute Renal injury caused by Snake bite envenomation14 
23 
 
Early administration of appropriate anti-snake venom is the specific 
treatment in snake envenomation. Early Complete neutralization of effects 
of venom  will cause zero morbidity and mortality, but this is not actually 
happens. 
Salem city is surrounded by hills; Nagarhills on the north, Jaruguhills on 
the south,Shevaroy hills on the northeast,Goduhills on the east and 
Kariyaperumal hills in the southwestern. The Cauvery river flows through 
the district and the Mettur dam was built across the river. So Agriculture is 
the principal means of livelihood inSalem and itsnear by districts. The 
district is heavily infested with venomous snakes, and the victims of snake 
bite are mostly healthy youngpersons mostly belonging to the lower socio-
economic strata, most of them bread winners of the family. 
THE GOVERNMENT MOHAN KUMARAMANGALAM 
MEDICAL COLLEGE HOSPITAL is one of the best Multispeciality 
government hospitalin Tamilnadu. It receives Patients from 6 districts 
(Salem, Namakkal,Erode, Trichy,Villupuram,Dharmapuri,Krishnagiri) in 
the North-western Tamilnadu. 
The study has been conducted to assess incidence of acute kidney injury 
and it’s clinical, haemodynamic and investigation profiles and outcome of 
patients admitted with snakebite and systemic envenomation in GMKMC 
HOSPITAL, SALEM. 
  
24 
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AIMS & OBJECTIVES OF STUDY 
 
This is a prospective study of snakebite with systemic envenomation 
  
 To study the incidence of acute kidney injury, Clinical, 
hemodynamic and investigation profiles of patients admitted 
with snakebite and systemicenvenomation. 
 To analyse the outcome of patients in relation to multiple 
factors like bite and needle time, amount of Inj.ASV 
administered and other factors. 
 To know whether there is any age or sex predilection for the 
severity of envenomation.  
 To define and classify Patients with AKI according to AKIN 
staging and to know causative factors for development of AKI. 
 To know outcome of Patients with AKI with various 
managements. 
 100 Patients admitted in various medicalwards from 
1.04.2015to31.03.2016 were taken up for the study. 
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REVIEW OF LITERATURE 
HISTORICAL ASPECTS 
Snakes are elongated, legless carnivorous Reptiles of the suborder 
Serpentines, which do not have eyelids and external ears. Their apparent 
renewal of life with casting of skin and the power of some of them to 
inflict suffering and death have given them a supernatural aura which 
made them worthy of worship by some ethnic groups. In Indian 
mythology, Cobra was worshipped as Naga. “Aadishesha on 
whom Vishnu does yoga nidra, Vasuki is the king of Nagas, 
Kaliya poisoned the Yamuna river where he lived,Krishna subdued Kaliya 
and compelled him to leave the river, Manasa is the queen of the snakes 
are wonderful tales of famous snakes in Indian mythology”. In ancient 
Greek, it was believed that “Aesculapius would crawl across the bodies of 
sick people asleep at night in his shrines and lick them back to health”. In 
India, snake bite was treated by many cruel methods like making local 
incisions, pricks, punctures, attempting to suck the venom bit bite mark, 
using snake stones and application of chemicals, herbals on the bite mark. 
The most important landmark in the treatment of snake envenomation was 
the development of anti-snake venom. It was prepared by Albert Calmette 
in 1890, when his village flooded and monocled cobras killed more than 
40 people in his village4. Hence he caught a few snakes, milked them of 
their venom and injected into horses to create antibodies. Other prominent 
28 
 
names in the development of anti snake venom are Acton, Knowll and 
Fraser.  Ahiya M.L found that antivenom to Indian cobra was effective 
against South African cobras.Lamb and his successors produced 
antivenom against Russell’s viper in India.
6
Later came the polyvalent 
antivenomfrom  the central research institute, Kasauli. The Later 
developments were supportive measures like dialysis and blood 
component therapy. Latest trends are rapid immunodiagnostics and 
administration of specific monovalent anti venom, development of 
antivenom against locally seen snakes and development ofvaccine.7,8 
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EPIDEMIOLOGY 
        Snakes do not ordinarily prey on humans. Unless it was startled or 
injured, most of the snakes preferred to avoid contact with humans. 
“Snakebite is one of the most neglected public health issues in poor rural 
communities living in the tropics”20. Most snakebites are occurred on the 
lower limb of agricultural workers and children living in rural areas. Since 
in developing countries like India where” the majority of the victims are 
initially treated by professional snake healers, snake charmers and 
religious men who use herbal remedies, ‘mantras’ and apply snake stone 
to the wound, all of which are supposed to magically draw out the venom 
from the victim”9 In India ,46000 people (99% CI 41000-51000) die from 
snakebite each year, a figure based on verbal autopsy of all deaths in 6671 
randomly chosen sample areas throughout the country26- (Mohapatra B 
2011). Snake bite was responsible for 0.5% of all deaths, 97% of the 
victims died in rural areas, only 23% in health facility32. 
          No significant difference in the severity of snake envenomation was 
reported between males and females, even though, the male to female ratio 
of bite varied from 3:1 to 4:3 in various studies. The study from Gujarat 
also reports that more bites occur during daytime (7:3) but there is no 
mention about diurnal variation of severity of bite. Krait is a nocturnal 
snake, so majority of the bite will around 12am to 4 am, most of the 
patients will be unaware of the bite, presented with neurotoxicity in the 
30 
 
morning, often misdiagnosed as cerebro vascular accidents22. 
In rural areas, Victims often do not find the species of snake or 
misdiagnose to another species, especially Cobra. This is common with 
female and children. Due to poor knowledge regarding snakes, poor 
visibility, frightness on seeing the snakesetc.leads to poor identification of 
snakes18. 
SNAKE BITE IN INDIA 
The numbers of snake-bite fatalities in India has long been controversial. 
“It was Estimated as low as 61 507 bites and 1,124 deaths in 2006and 
76,948 bites and 1,359 deaths in 2007 [Government of India data: P 108 of 
http://cbhidghs.nic.in/writereaddata/mainlinkFile/Health%20Status%20In
dicators.pdf) and as high as 50 000 deaths each year have been published 
and the Registrar-General of India’s “Million Death Study”, 2001-2003, is 
expected to provide reliable evidence of substantial mortality (exceeding 
50 000 per year) as it is based on Representative, Re-sampled, Routine 
Household Interview of Mortality with Medical Evaluation (RHIME), 
covering all age groups across the entire country with geographical, 
seasonal and occupational data.”In 1992, Hati et al did a large field survey 
in the villages of Burdwan district of West Bengal revealed that every year 
8000 people were bitten by snakes, among them 800 peoples died11.
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SNAKES  
       Of the 3346 species of snakes are identified in the world over, but 
only 667 of these having fangs ventrally, can inject the venom while biting 
human or animals.. In India there are about 242 species of snakes of which 
57 are poisonous
21
and belong to the family of Eliapidae, Colubridae, and 
Viperidae. Bites of Viperidae, Crotalidae and Colubridae usually have 
hemostatic abnormalities and features of local envenomation. The 
Elapidae is commonly producing neurological signs like descending 
paralysis and Hydrophidae causes Rhabdomyolysis. The carpet or saw 
scaled viper (EchisCarinatus) justifiably is one of  the most dangerous 
snake in the world.
7,8 
VENOMOUS SNAKES 
         Venomous snakes are of 3 families 
ATRACTASPIDINAE – also called adders or false vipers. Very long 
solenoglyphous( hinged erectile fangs). Also called side stabbing/stiletto 
snakes, because they attack their victims by side swiping motion, and the 
fangs are protruding from the corner of the partially closed mouth7. 
ELAPIDAE – short fixed proteoglypous (short fixed fangs). This includes 
cobras, kraits, mambas, coral snakes and sea snakes. 
VIPERIDAE - This includes old world vipers and pit vipers. Old world 
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vipers have long curved hinged fangs in the front which contains a closed 
venom channel. Pit vipers has an infrared heat sensitive organ to identify 
warm blooded animals. 
OTHER NON-VENOMOUS SNAKES: 
BORDAE FAMILY – called the giant constrictors and known for 
swallowing the victims. Examples: Reticulated pythons, African rock 
pythons, South American anaconda, Australian serous Python. 
COLUSRIDAE FAMILY – largest family of snakes, includes 1748 
species. 
   The quantity of venom injected every first bite of snake and fatal dose 
for men varies in different snakes. Sometimes 1/6 of amount of venom is 
fatal for healthy human. For e.g. Cobra bite. 
Table.1. Dry weight and fatal dose of venom of various snake Species4. 
Snake species Dry weight of venom 
(mg) 
Fatal dose (mg) 
Spectacled Cobra 60 12 
Krait 20 6 
Russell Viper 63 15 
Saw scaled Viper 13 8 
WHO categorized poisonous snakes of India according to the severity of 
envenomation treated with more importance as follows4. 
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WHO - MEDICALLY IMPORTANT SNAKES IN INDIA 
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THE BIG FOUR SNAKES  
COMMON COBRA : 
Zoological Name :NajaNaja 
Family                 :Elapidae 
Location             : Commonly seen in India, Pakistan, Bangladesh, Nepal. 
In India, it is abundantly seen in Assam & Kashmir. 
Tamil Name        : நாகÜபாÝ®/நàலபாÝ® 
Appearance     :Ventral scales may be grey, yellow, black or brown. 
Dorsal scales may bear a hood mark or sometimes salt & pepper speckles 
may be seen. When hood is present 2 circular ocelli patterns get connected 
by a curved line resembling a spectacle. It is of length 1 – 1.5m.  
Identifying Features:It expands the head when threatened and forms 
hood. In the dorsal aspect of hood, spectacle shaped mark will be present. 
INDIAN KRAIT (BLUE KRAIT) : 
Zoological Name:BungarusCaeruleus 
Family                : Elapidae 
Tamil Name       : கØ©யå  
Location: Commonly seen in south India & Sri Lanka.  
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IMAGES OF ELAPIDAE SPECIES 
 
  
 
Figure 2.1. SPECTACLED COBRA WITH 
HOOD   
 
Figure 2.2. COBRA WITH SPECTACLE 
 
  
  
 
Figure 2.3 DORSAL SURFACE OF 
KRAIT 
 
Figure 2.3. VENTRAL ASPECT OF 
INDIAN KRAIT 
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Appearance         : Head is flat with hardly evident neck. The head shields 
are normal with no laurels. It is generally black in colour with white 
crossbars in the dorsal side. The ventral part (belly) of the snake is pure 
white in colour without scales.  
Behaviour : During day it is sluggish & generally inactive whereas at 
night it is active & escapes from rodent holes or loose soil by hissing 
loudly. When it was agitated, it will make coils and insert the head into the 
coils &body become flatten.  
RUSSELL’S VIPER ( CHAIN VIPER / SEVEN PACER / SCISSOR 
SNAKE ) : 
Zoological Name: DabioaRusselli 
Family                 : Viperidae 
Location: Commonly seen in India, Pakistan, Sri Lanka, Bangladesh, 
Nepal, and Thailand. In India, it is seen abundantly in Punjab, along West 
coast & its hills, in southern India & North to Bengal. 
Tamil Name     :கÙணா}யå 
Appearance     : It has a triangular head & the crown of which bears 
irregular strongly fragmented scales. Dorsal scales are highly keeled & the 
ventral scales are 153 – 180 in number. The head has a pair of distinct 
dark patches one on each temple with brownish V or X marking to form 
37 
 
an apex. The maxillary bones bear around 2-6 pairs of fangs at a time with 
1st being active & the others being replacements. Maximum length of this 
type is around 5.5 feet. 
Identifying feature:  It behaves as a nocturnal forager but during winter it 
becomes active during day time. When threatened it forms a series of S 
loops, raise the proximal third of the body & produce a hiss. 
SAW SCALED VIPER: 
Zoological Name:Echiscarinatus.  
Family                 : Viperidae 
Tamil Name        :  ¦±Øைடயå 
Location              : India, Pakistan, Sri Lanka, Bangladesh. 
Appearance : The head is distinct from neck covered with dorsal keeled 
scales & ventral rounded scales. Colour pattern – pale buff, greyish or 
reddish with series of variably coloured spots with lighter interblotch 
patches.  
Behaviour:It is mostly crepuscular & nocturnal. Most active after rains or 
on humid nights. Typical pose – a double coil with figure of eight with 
head poised in the centerpermitting it to lash out like a released. 
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POISONOUS SPECIES OF VIPERIDAE FAMILY 
 
Figure  3.1 Dorsal aspect of   Figure 3.2 Ventral aspect of  
           Russell viper     Russell Viper 
 
 
 
Figure 3.3. SAW SCALED VIPER 
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IMAGES OF POISONOUS AND NON-POISONOUS SNAKES 
OTHER THAN BIG FOUR SNAKES 
 
 
Figure 4.1. KING COBRA  Figure 4.2. HUMP NOSED PIT VIPER 
 
 
COMMON NON- POISONOUS SNAKES IN INDIA 
 
Figure 4.3.RAT SNAKE                            Figure 4.4. INDIAN ROCK 
PYTHON 
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SNAKE VENOM 
Snake venom is protein in nature, contains so many polypeptides,enzymes 
and coagulant and anticoagulant substances.Itisrich bio-resource of 
biologically active compounds, identification and characterization of toxic 
compounds present in each snake venom is the main step not only to 
understand the pathophysiological changes but they can also be useful to 
improve the treatment after snake bite43. 
 
Fig.4) Snake venom apparatus 
NATURE OF VENOM: 
PHYSICAL APPEARANCE: 
    Snake venom is a clear, transparent, pale yellow or straw-coloured 
viscous fluid. It is thermos labile; having a specific gravity of 1.03-
1.07.The pH of the venom varies in different species and also  when they 
exposed to sun, they turns slightly  turbid34 .It can be dried as crystals or 
lyophilized and dried venom is thermo-stable.It is soluble in 
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waterandglycerine. It is destroyed by coagulating agents like KMnO4, 
AgNO3, as well as alcohol and strong alkalies like NaOH and KOH, etc46.  
 
Fig.5). Physical appearance of Snake Venom 
BIOCHEMICAL CONSTITUENTS OF SNAKE VENOM ; 
Snake venom contains varying proportions of enzymes, non enzymatic 
toxins, nontoxic proteins and acetyl choline. 
Enzymes: 
Enzymes constitute about 10 – 90 % of viperid and 25 – 75 % of elapid 
venoms. Various enzymes of snakes are discussed below. 
Proteinases:They cause significant tissue changes and destruction 
because of the digestion of tissue protein and peptides. Enzymes liberate 
histamines from the damaged endothelium which leads to dissolution of 
blood vessels. 
Hyaluronidases:This enzyme helps in the rapid diffusion of venom from 
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the site of bite by hydrolysis of hyaluronic acid present in the connective 
tissue. 
Acetyl Choline Esterase:Formed mainly in elapid venom, it facilitate the 
cleavage of acetyl choline to acetic acid and choline, which leads to 
impairment of neuromuscular transmission46. 
Phospholipase:Phospholipase A2 has a direct hydrolysing action on the 
cell membrane and indirectly produces haemolytic agents like lysolecithin, 
hence facilitating haemolysis. 
Phosphodiesterase:Ittargets the DNA, RNA and nucleotide derivatives. 
This is responsible for the fall in systemic arterial pressure55. 
Acetyl choline:It has the direct cardiac action or on neuromuscular 
junction. 
Metalloproteinases :It causes disruption of the endothelial lining and is 
the main cause of cellulitis7. 
 
PRO COAGULANTACTIVITIES: 
      Snake venom contains many Procoagulants which interact at 
coagulation cascade and activate coagulation mechanisms which results in 
formation micro thrombi (DIC like mechanism) and consumption 
coagulopathy which is the cause for prolonged clotting time in Snake 
bite8. 
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Direct prothrombin activator: 
This unnamed substance which directly activates of prothrombin of 
Human And Bovine does not requires any activation , cleaves one or more 
peptide bonds, which generate a catalytically active intermediate which 
undergoes auto conversion to thrombus. 
      This mechanism is also observed with Elapid,Viperid and Colubride 
venom bite,not in the case of Crotalids. 
Factor V activator: 
  A specific peptide in Russell Viper venom activates Factor V and 
activates Clotting cascade. 
Factor X activator: 
      Macfarlane discovered that a specific substance which present in 
Russell Viper venom activates Factor X in the presence of Calcium, which 
induces a conformational changes in Factor X14. 
Factor IX Activator: 
    Factor X activator presents in the Russell Viper also activates Factor IX 
also. 
Indirect prothrombin Activator: 
        This factor along with Activated factor X convertsprothrombin to 
Thrombin which is the prime material of thrombus formation.  
Thrombin like Peptides: 
      Venom of Viperidae contains some Glycopeptides, which cannot be 
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inhibited by direct thrombin inhibitor like Heparin. This enzymes release 
Fibrinolytic peptide A&B,which directly activates thrombin34. 
ANTI-COAGULANTACTIVITIES:  
 Snake venom contains anti coagulants in addition to pro coagulants, they 
causes anticoagulation by following mechanisms: 
 Inhibition of one or more clotting factor or prevention of activation 
of clotting factor. 
 Directly activating on Fibrinogen and causes Fibrinolysis. 
 Activation of plasminogen or proactive Plasminogen directly which 
causes fibrinolysis. 
NON-ENZYMATIC POLYPEPTIDE TOXINS PROTIENS: 
Toxins in snake venom is broadly classified into two groups- neurotoxins  
and hemotoxins, but there are more than two types of toxins they are 
myotoxin , cardiotoxins.no venom contains one type toxins, most snake 
have combination of  toxins. 
HEMOTOXINS: 
     Toxin acts by lysing erythrocytes , it disrupts blood clotting processes, 
also severely damages the internal organs and other tissues.  Generally 
these toxins acts slower than neurotoxins. Toxins of most vipers and 
many cobra species are hemotoxins2. 
CARDIOTOXIN: 
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These specifically binds to myocardial cells and increase cellular 
depolarisation and resulted in inhibition of contraction of heart. 
   The toxins sometimes release calcium from surface membrane of 
myocardium resulted in cardiac arrest. 
 Some of substances increase vascular leak producing “Capillary Leak 
Syndrome” which causes intravascular hypovolemia and third space fluid 
collection, all resulted in shock4. 
NEUROTOXINS:  
    Neurotoxins are low molecular weight exclusively found in Elapidae 
species, also in Hydrophid,Vipridae,Crotalid venoms. It is fast acting 
toxins. Neurotoxins fall in two groups they are postsynaptic neurotoxins: 
POST SYNAPTIC BLOCKING TOXINS : 
Alpha-neurotoxins such as alpha-Bungarotoxins and Cobratoxins are a 
large group, binds to the Nicotinic acetylcholine receptors of cholinergic 
neurons present in motor end-plates of skeletal muscle, since they mimic 
the shape of the acetylcholine molecule and it binds to the receptors  and  
block the acetylcholine flow which leads to feeling of numbness and 
paralysis. 
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Fig. 6).Neuro muscular blockade mechanism of cobra venom. 
PRESYNAPTIC NEUROTOXINS: 
Beta-neurotoxins or presynaptic phospholipases A2 such as beta-
bungarotoxins, crotoxin, taipoxin.Presynaptic neurotoxin produces 
neuromuscular blockade by inhibiting acetylcholine release from 
presynaptic membrane and causes progressive flaccid paralysis8. 
FASCICULINS: 
Theseare synergistic neurotoxins, inhibits acetylcholine Esterasesresults in 
accumulation of Ach this cause severe, generalized and long-lasting (5-7 
h) fasciculations (rapid muscle contractions),which may leads to 
death.Mostly it found in mambas and some rattle snakes. 
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Fig. 7).Neuro muscular blockade mechanism of Krait Venom 
DENDROTOXINS: 
Dendrotoxins also an synergistic toxins which inhibit neurotransmissions 
by binding tovoltage-gated potassium channels and  blocking the 
exchange of positive and negative ions across the neuronal membrane lead 
to no nerve impulse, thereby paralysing the nerves.it also seen mambas .k-
bungarotoxins, which bind to somespecific nicotinic acetylcholine 
receptors in the brain andvarious ganglia. 
CYTOLYSINS:  
It causes lysis of cell structures of blood and tissue, resulting in swelling, 
cellulitis, bleb formation and rarely necrosis11.  
SYMPTOMATOLOGY 
GENERAL SYMPTOMS: 
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SYMPTOMS NOT RELATED TO ENVENOMATION 
The snake bite victims will develop frightness, anxiety, palpitations, 
syncopal attack as thought of death or consequences of snake bite 
envenomation. 
Some of the patients will develop anxiety, hyperventilation, increased 
sweating which may confuse with systemic manifestations of Neurotoxic 
snake bites. 
Native irrational treatment done by traditional healers or relatives like 
incision over bite mark, application of irritants, Plant juices etc which may 
produce irrational symptoms and signs which may mislead our diagnosis 
and management. 
Other common symptoms are headache,Nausea, vomiting, abdominal 
colicky, drowsiness, fatigability. 
LOCAL SYMPTOMS: 
 Fang or bite marks of snake 
 Pain at the bitten area 
 Swelling 
 Bleeding from Fang marks 
 Bruising  
 Localised tender lymphadenopathy 
 Bullae formation,  
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 Local infection, Necrosis, Gangrene. 
 
Fig. 9). Bite marks of Poisonous and Non-Poisonous Snakes 
SYSTEMIC SYMPTOMS: 
It depends upon the species of snake which bites and amount and potency 
of venom injected. Most of the times the symptoms and signs will 
correlate with species of snake if it was identified, hence the species of 
snake can be  retrospectively identified with patient’s description, 
circumstances of bite and the features of envenomation. 
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Figure.10. General symptoms of snake bite envenomation 
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VIPERID ENVENOMATION 
LOCAL ENVENOMING:  
Venoms of vipers and pit vipers produce severe local effect. It is mainly 
hemotoxic and also will produce neurotoxic manifestations rarely. 
1. PAIN 
When the snake bites, the fang will pierce the skin, subcutaneous tissue 
which will produce pain initially, it may disappear if the snake didn’t 
inject the venom in case of dry bite or non poisonous snake. 
     The venom itself is a irritant and also contains so many proteases and 
metalloproteinases which cause tissue damage, inflammation which will 
produce continuous pain. 
      Ascending cellulitis, lymphangitis, rapidly forming swelling and 
accumulation of fluid, vascular occlusions, secondary bacterial infections 
and ischemia, gangrene formation and compartmental syndrome are the 
causes for excruciating continuous pain in snake bite envenomation. 
2. SWELLING OF BITTEN AREA: 
Viper’s venom will produce severe local effect. Swelling usually appears 
within 15 minutes, but rarely is delayed for several hours. It spreads 
rapidly, sometimes to involve the whole limb and adjacent trunk. If the 
swelling is rapidly evolving it can be used to assume as Viper 
envenomation, if the snake was not identified. Patient will also have 
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painful, tender localised lymphadenopathy. Bruising, especially in path of 
superficial lymphatics, also over the regional lymph nodes, is common. 
Swollen limbs can accommodate many litres of extravasated blood, 
leading to hypovolemic shock. Most viper venoms are predominately 
vasculotoxic causing localised swelling around the bite mark, is due to 
diffusion of venom through the superficial tissue. Venom 
metalloproteinase hemorrhagins, membrane damaging polypeptide toxins, 
phospholipases, and endogenous autacoids such as histamine, serotonin 
and kilims are responsible. 
The swelling part will be shiny with stretched skin. It will tender on 
palpation and will extend centripetally may extend up to groin from foot, 
up to axilla in case of bite in the hands. Sometimes it may spread to 
opposite part of the body in case of severe envenomation caused byVipers.
 
Fig. 11). Cellulitis of bitten limb 
Absence of detectable local swelling 2 hours after a viper bite usually 
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means that no venom has been injected. However, there are important 
exceptions to this rule: 
3. ECCHYMOSIS: 
Discoloration of the skin over the swollen area appears after few hours of 
bite. It depends on the amount of venom injected and the species which 
bite. It is one of the sign of severe coagulopathy. 
4. BULLAE FORMATION: 
     In case of Viper bite bullae will appear within 8 hours and it is 
depending upon the potency and amount of venom injected. If 
envenomation is moderate, the bullae will be filled with clear, serous 
fluid. In case severe envenomation with coagulopathy, haemorrhagic 
bullae will form, it ruptures often and produce ulcers.
35 
 
Fig. 12).Hemorrhagic and Non- hemorrhagic bullae around the bite mark 
 
5.GANGRENE AND NECROSIS: 
    Bites on the digits and in areas draining into the tight 
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fascialcompartments, such as the anterior tibial compartment, are 
particularly likely to result in necrosis. High intra compartmental pressure 
may cause ischaemia which contributes, together with direct effects of the 
venom, to muscle necrosis. 
 
SYSTEMIC MANIFESTATIONS 
CIRCULATORY SHOCK 
The peptide and protein content of the venom leads to action of kinin 
system, which is followed by inhibition of bradykinin system.  
Shock is one of the leading cause of death in viper bites. It can be either 
due to hypovolemia from extravasation of blood into the tissue, cardiac 
abnormalities are due to loss of integrity of the vascular endothelium. 
Swollen limb can accommodate many litres of extravasated blood leading 
of hypovolemic shock, which can take place between 6 to 26 hours after 
envenomation. 
Shock is further worsened by hemolysis with renal and respiratory failure, 
which can occur early or three to four days after the bite. 
 
HEMOSTATIC ABNORMALITES 
   Viper is mainly hemotoxic, makinghaemorrhage is the most prominent 
symptom of systemic envenomation. 
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Haemorrhagins are the special toxic constituents, present in viper venom 
out of which aminoacid esterase, specifically activates factor XII, which 
plays a main role in bleeding due to consumption of coagulation factors as 
in DIC. 
 
Fig. 13).Hemostatic and neurotoxic mechanisms of snake venom 
Proteases. 
Another mechanism called fibrinogenolysis, has been postulated in the 
bleeding secondary to Echiscarinatus bites. (V.N.Acharya36 1981). R.K. 
Saini37of SMGS Hospital and government medical college, Jammu, who 
studied 150 cases of viper bites, found that 92%  had evidence of primary 
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fibrinogenolysis whereas only 8%  had DIC37. 
Spontaneous systemic haemorrhage is most often detected in the gingival 
sulci. Blood staining of saliva and sputum usually reflects bleeding gums 
or epistaxis. True haemoptysis is rare. Haematuria may be detected a few 
hours after the bite.  
Other types of spontaneous bleeding are Ecchymoses, intracranial and 
subconjuctivalhaemorrhages, bleeding into the floor of the mouth, 
tympanic membrane and gastrointestinal and genitourinary tracts, 
petechiae and larger discoid and follicular haemorrhages.  
Bleeding into the anterior pituitary (resembling Sheehan’s syndrome) may 
complicate envenoming by Russell’s vipers. Persistent bleeding (>10 
minutes) from the fang puncture wounds and from new injuries such as 
venepuncture sites and old partially healed wounds is the first clinical 
evidence of consumption coagulopathy. 
Formation of haemorrhagic blebs with uncontrolled bleeding from the site 
of bite, is the earliest sign of haematotoxicity in viper bites. 
Patients present with ecchymosis, purpura and hematoma within 2 – 24 
hours of bite :Schwartzman like phenomenon 
The most common symptoms of hematotoxityisHematuria (microscopic or 
frank) followed by Hemetemesis, Malena, Gum bleed, Hemoptysis. 
Cerebral haemorrhage can also occur4. 
Mortality usually occurs due to shock and haemorrhage. Acute renal 
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failure can occur due to occlusion of renal vasculature by micro thrombi, 
shock and hypovolemia. Intravascular hemolysis manifests as 
hemoglobinemia and hemoglobinuria45. 
Peripheral smear showing fragmented erythrocytes, is an indication of 
microangiopathichemolysis associated with severe anemia and acute renal 
failure. 
CARDIOVASCULAR MANIFESTATIONS: 
Viper bite leads to disturbances in victim, collapse, hypotension, shock, 
pulmonary edema, chemosis, arrhythmias. 
NEUROLOGICAL MANIFESTAIONS: 
Drowsiness, alteration in olfaction, ptosis, external opthalmoplegia, facial 
muscle paralysis, nasal twang of voice, aphonia, nasal regurgitation, 
dysphagia, respiratory paralysis, acute flaccid paralysis are the common 
neurological manifestations4. 
Viperid neurotoxicity is usually attributed to venom phospholipase A2 , it 
is a feature of envenoming by Crotalusdurissusterrificus, small south 
African bitis species, and Indian and srilankanRussells viper’s 
(DusotaRussellis). Paralysis descends on with elapid envenoming and 
progresses to bullae and respiratory muscles. 
Rhabdomyolysis manifests as generalized myalgia and muscle tenderness. 
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Fig. 14).Various toxic manifestations of snake venom and their 
mechanisms 
 
ELAPID ENVENOMATION 
Most of the victims develop no local effects but develop neurotoxic 
features like ptosis, opthalmoplegia, respiratory paralysis etc. 
LOCAL SIGNS OF ENVENOMATION: 
 Krait usually does not produces local envenomation effect. 
 Severe local burning pain is a presenting feature of a cobra bite. 
 Because of the direct cytolytic action of cobra venom, local necrosis 
in cobra bite occurs. 
 But in King cobra (Ophiophagus Hannah) bite, local necrosis is 
minimal but in results in swelling of the limb and formation of 
bullae. 
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NEUROTOXIC SYMPTOMS: 
 The first symptom of systemic envenomation is repeated vomiting 
 Earliest sign of neurotoxicity is drowsiness which occurs between 
15 mins to 5 hours of envenomation 
 But the most common and earliest manifestation is bilateral ptosis 
 Patients experience difficulty in vision, double vision, immobility of 
the eyeball 
 These eye signs are of prime importance  as they are the only 
evidence of muscle paralysis in small doses of envenomation 
 The other preparalytic signs are blurred vision, paraesthesia, loss of 
olfactory and gustatory sense, hyperacusis, vertigo , headache and 
other autonomic symptoms like conjuntival congestion, gooseflesh, 
increased salivation 
 All the above preparalytic signs develop between 1 – 4 hours of bite 
 Paralysis is first manifested by ptosis and external opthalmoplegia 
 It can either appear early as 15 minutes after the envenomation or a 
late as 10 hours following the bite 
 This is followed by paralysis of facial muscles, tongue, vocal cords, 
neck muscles and muscles of deglutition which is then followed by 
dilation of pupils depending on the severity of envenomation. 
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 According to the severity of envenomation, the symptoms may be 
insidious in onset or rapid. 
 The patient experiences difficulty inn speech, nasal twang due to 
palatal palsy, difficulty in opening the mouth and swallowing. 
 In very severe cases, intercostal muscle paralysis manifests as 
decreased outward rib movement and by absence of increased 
intercostal tension. 
 The respiration becomes diaphragmatic which is followed by 
complete paralysis. 
 Stupor, shallow breathing, increase in pulse, BP, respiratory rate, 
cyanoses and increased sweating are the signs of respiratory failure. 
 During this stage, patient condition can be worsened by non- 
reactive pupils, deepening of coma, twitching, convulsions which is 
then followed by death. 
 Limb weakness is the last to develop. 
 Proximal muscles are most affected by varying grades of flaccid lim 
paresis. 
 This is followed by a completely flaccid quadriplegia in which deep 
tendon reflexes are lost. 
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 The progressive graph of symptoms from early ptosis to terminal 
respiratory failure is strikingly similar to the course of myasthenia 
gravis4. 
HEMATOTOXIC SYMPTOMS: 
Coagulopathy will usually occur with Asian cobra bite, but not with 
kraits.The mechanism of coagulopathy is similar to viperid 
envenomationBut internal bleeding, intravascular hemolysis and acute 
kidney injury are uncommon with elapid species. 
CARDIOTOXIC SYMPTOMS: 
These symptoms occurs due to the direct acting cardiotoxins. They are 
sudden in onset and in severe cases manifests as sweating, cold 
extremities, hypotension, tachycardia, ST – segment T wave changes 
which then goes on adownward spiral to hypotension, arrhythmias and 
cardiac arrest. 
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MANAGEMENT OF SNAKE-BITE  
Steps to be followed in the management of snake bite is as follows 
1. First Aid 
2. Shift the patient to the nearby hospital 
3. Resuscitation 
4. History and Clinical examination 
5. Investigations 
6. ASV treatment 
7. Supportive Management 
8. Treatment of complications like Respiratory Failure, Acute 
Kidney Injury 
9. Treatment for the local wounds  
10. Rehabilitation 
FIRST AID TREATMENT 
It is the initial care given to the patient by others or even by himself. It 
is very important in the steps of management, as it delays the 
absorption of venom. 
DO’S AND DON’TS IN FIRST AID 
 Relieve the anxiety of the patient 
 Immobilize the patient either partly or wholly, because on moving 
the part of body, muscular contraction will increase the absorption 
63 
 
of venom, as superficial lymphatics will carry the venom to 
systemic circulation. 
 “If the necessary equipment and skills are available, consider 
pressure-immobilization or pressure pad unless an elapid bite can be 
excluded. In Myanmar, the pressure pad method has proved 
effective in victims of Russell’s viper bite” - (TunPe et al., 1995)37. 
 “Avoid any interference with the bite wound (incisions, rubbing, 
vigorous cleaning, massage, application of herbs or chemicals) as 
this may introduce infection, increase absorption of the venom and 
increase local bleeding” - (Bhat, 1974)54. 
Release of tight bands, bandages and ligatures:  
Tourniquets should not be used. If applied, sudden release may cause 
flushing of venom into the circulation may cause sudden hypotension, 
severe coagulopathy etc. 
“ Ideally these should not be released until the patient is under medical 
care in hospital, resuscitation facilities are available and antivenom 
treatment has been started” - (Watt et al., 1988)52. 
 
HARMFUL METHODS OF FIRST AID TREATMENT : 
 Incising the bite mark, Hence the blood mixed with venom will 
bleed out. 
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 Try to sucking the venom out. 
 Applying tourniquets, tight bands just above the bitten area, it was 
believed that it will obstruct the entry of venom into systemic 
circulation. 
 Giving electric Shock over bite mark.   
 Application of chemicals, Plant Juices over bite mark. 
Rural people will have strong beliefs on traditional treatments, it should be 
encouraged as it will cause delay in specific treatment, sometimes it will 
confuse with local envenoming signs and sometimes in case of 
coagulopathy, continuous bleeding may occur from incised wounds. 
 
Fig. 15). Tourniquet was applied in right lower limb above bitten area 
TIGHT (ARTERIAL) TOURNIQUETS ARE NOT RECOMMENDED!  
“MOST TRADITIONAL FIRST AID METHODS SHOULD BE 
DISCOURAGED : THEY DO MORE HARM THAN GOOD !4” 
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TRANSPORT TO HOSPITAL : 
 The victim should be transported to nearby Government Hospital or 
healthcare facility immediately. 
 He can be shifted by using motor vehicles, bicycle,train in resting 
position, if possible should be transported by using Ambulance. 
INITIAL RESUSCITATION : 
After receiving the patient, he should resuscitated as all medical 
emergency, 
“ABCDE APPROACH” 
1. “Airway patency 
2. Breathing (respiratory movements 
3. Circulation (arterial pulse) 
4. Disability of the nervous system (level of consciousness) 
5. Exposure and environmental control (protect from cold, risk of 
drowning etc.)4 
HISTORY AND PHYSICAL EXAMINATION : 
History 
      A short history of the circumstances of the bite and the progression of 
local and systemic symptoms and signs are very important to assess the 
severity of envenomation and assume the species if the bitten snake was 
not identified by the victim. 
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Four important  questions to be asked: 
i. “In what part of your body have you been bitten?” 
ii. “When and under what circumstances were you bitten?” 
iii. “Where is the snake that bit you?” 
iv. “How are you feeling now?” 
Species identification is important to predict complications, not for 
treatment. So importance should be given for treatment only. Vomiting 
and abdominal pain are the earliest symptoms of systemic envenomation. 
Some patients may develop headache also. History regarding bleeding 
manifestations and diarrhoea, double vision should be recorded. 
 
“Early clues that a patient has severe envenoming: 
 Snake identified as a very dangerous one. 
 Rapid early extension of local swelling from the site of the bite. 
 Early tender enlargement of local lymph nodes, indicating spread of venom 
in the lymphatic system. 
 Early systemic symptoms: collapse (hypotension, shock), nausea, vomiting, 
diarrhoea, severe headache, “heaviness” of the eyelids, inappropriate 
(pathological) drowsiness or early ptosis/ophthalmoplegia. 
 Early spontaneous systemic bleeding. 
 Passage of dark brown/black urine.4” 
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PHYSICAL EXAMINATION : 
 Physical examination should be done carefully, concentrating both local 
as well as systemic signs of envenomation. 
EXAMINATION OF THE BITTEN PART:  
Bite mark : 
  Venomous snakes will have single fang, usually produce single mark, 
unless it bitten multiple times, but it is uncommon. Multiple scratch like 
teeth marks is an important one to differentiate the snake which bite is 
venoumous or non-venomous, because most of the venomous snakes have 
single fang. “The presence of isolated fang marks,when related to 
venomous snake bite,had a sensitivity of 100%, a specificity of 56% and a 
predictive value of 89%. The finding of multiple scratch like teeth marks 
had a predictive value of 100%when related to non venomous snake 
bite15” -(Nishiokasde et al 1995) 
 
Fig. 16).Bite marks of poisonous and Non poisonous snake bite 
     Next to bite mark swelling around the bite mark should be assessed. 
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The extension of swelling, color of skin , presence of bullae, vesicles 
should be recorded. Extension of swelling should be marked. 
     The regional lymphnodes should be palpated and tender 
lymphadenopathy should be recorded. 
GENERAL EXAMINATION:  
Consciousness  and orientation will be impaired in cases of neurotoxic 
snake bite patients and patients with shock and respiratory paralysis. 
          Pallor is a indicator of internal bleeding and obscured GI bleeding. 
Cyanosis may be noted in patients with respiratory failure. 
     Vital signs such as Blood Pressure, Pulse and Respiratory rate should 
be recorded. Postural drop in Blood Pressure is recorded, it may be a early 
sign of Hypovolemia. 
Skin all over the body for Petechiae, Ecchymosis, subconjunctival 
Hemorrhages should examined. 
Abdominal tenderness may be due to capillary leak syndrome or internal 
bleeding. Tenderness over flanks may be due to renal ischemia, occurs in 
Viper envenomation. 
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VARIOUS COMPLICATIONS OF SNAKE BITE 
  
Figure 17.1. Neck muscle Weakness. Figure 17.2. Gum bleeding Due to 
severe coagulopathy 
 
  
  
Figure 17.3 Ecchymosis of bitten 
limb 
Figure 17.4. Cellulitis of dorsum 
of Hand 
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NEUROTOXIC ENVENOMING: BULBAR AND RESPIRATORY 
PARALYSIS 
Ptosis, Numbness around mouth are the earlier signs. Extraocular 
movements should be checked. 
Neck muscle weakness is a warning sign of Respiratory paralysis, it 
should be checked frequently. 
Difficulty in Swallowing, nasal regurgitation, nasal twang of speech are 
signs of bulbar weakness, common in Elapidae envenomation. 
Paradoxical respiration – “abdomen expands rather than the chest on 
attempted inspiration” will occurs due to paralysed inert and subcostal 
muscles with acting diaphragm. 
        Single breath count may be used to assess the respiratory muscle 
weakness, but it become poor valid if patient was anxious. 
“Do not assume that snake bitten patients are unconscious or even irreversible 
“brain dead” just because their eyes are closed, they are unresponsive to 
painful stimuli, are areflexic, or have fixed dilated pupils.They may just be 
paralysed!4” 
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SUMMARY OF SIGNS AND SYMPTOMS OF 
SNAKE BITE IN INDIA 
 
Figure 18.Summary of signs and symptoms of snake bite in 
India 
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INVESTIGATIONS: 
COMPLETE HEMOGRAM 
Total and Differential Count : Polymorph nuclear leucocytosis will be 
present due to acute inflammatory response to snake venom. 
Hemoglobin and PCV: Due to extravasation of plasma, initially there is 
hemoconcentration followed by Anemia due to bleeding or Hemolysis 
Platelet Count:  Because of the direct effect of the venom or secondary to 
DIC, thrombocytopenia occurs after bite by ViperaRussellei and 
EchisCarinatus bites. It is directly proportional to the severity of 
envenomation in Russell and Saw scaled viper. 
Peripheral Smear: Due to Microangiopathichemolysis, fragmented red 
cells may be present 
Plasma / Serum: On account of elevated levels of Hemoglobin and 
myoglobin in the blood, the plasma may be pink or brown respectively 
BIOCHEMICAL ABNORMALITIES 
In case of muscle damage, aminotransferases and muscle enzymes are 
elevated. There is a slight increase in other enzymes picturing mild hepatic 
dysfunction. Due to extravasation of blood and hemolysis, bilirubin levels 
are elevated. In the renal failure caused by Russells viper, Hump nosed 
viper bites and sea snakes bites, potassium, creatinine, urea and BUN 
levels are raised. Sea snake bites cause extensive rhabdomyolysis, due to 
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which early hyperkalemia may be seen. In northern Vietnam, krait bites 
are reported occasionally to cause hypernatremia. In patients with AKI 
due to snakebites, bicarbonates levels are low as a result of metabolic 
acidosis. 
ARTERIAL BLOOD GASES AND PH: 
Neurotoxic envenoming and academia on account of respiratory and 
metabolic acidosis may lead to asymptomatic respiratory failure. 
PULSE OXIMETRY: 
It is the earliest non invasive method to monitor respiratory failure and 
shock 
URINE EXAMINATION : 
 Color of the urine is tested using dipsticks to detect the presence of 
blood/  hemoglobin/ myoglobin. 
 There is no reliable test to differentiate between the presence of 
hemoglobin / myoglobin in urine. 
 Erythrocytes in the urine can be confirmed by microscopy. 
 Presence of red cells casts reflect glomerular bleeding. 
In Russell viper bite, earliest sign of increase in capillary permeability and 
acute kidney injury is massive proteinuria. 
TESTS FOR HEMOSTATIC ABNORMALITIES: 
20 minute whole blood clotting time (20WBCT) : It is the optimal test 
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which requires only a single apparatus – a new, clean, dry glass bottle or 
tube. 2ml of fresh sample of venous blood are placed in the apparatus and 
left undisturbed for 20 minutes. On tipping the vessel, if the blood is still 
unclotted, it is indicative of hypofibrinogenemia due to venom induced 
consumptive coagulopathy. In case of doubt, the test is repeated including 
a control. 
THE PROTHROMBIN TIME: 
This test is done to assess extrinsic and common pathway of blood 
coagulation cascade. It is specific for Russell viper envenomation, but it is 
not done routinely for snake bite management.An enzyme which initiates 
coagulation by the direct activation of factor X and does not require the 
presence of factor VII. Stypen time is the one stage prothrombin time 
assay performed with Russells viper venom, which can distinguish 
between deficiency of factor VII and factor X. 
 
PARTIAL THROMBOPLASTIN TIME: 
It is a simple procedure to test the intrinsic and common pathways of 
coagulation but not under routine practice for assessing envenomation 
OTHER INVESTIGATIONS: 
Electrocardiography:ECG can be used to detect the electrolyte 
imbalance like hyperkalemia, hypokalemia etc. 
USG abdomen and Pelvis:It can be used to picture the morphology of 
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kidney, corticomedullary differentiation and other signs of capillary leak. 
ANTIVENOM TREATMENT:  
It is the only specific antidote to snake venom, discovered by Albert 
Calmatte in 1980 at the institute of Pasteur, in Saigon. The horse or 
donkey is immunized with venom of one or more species of snakes and 
the immunoglobulin purified from the plasma of animal is antivenom. 
Specific antivenom is one which has been developed against the particular 
snake, that has bitten the patient henceforth it can be expected to 
neutralize the particular venom and the venom of closely related species 
(para specific neutralization).Both monovalent and polyvalent antivenom 
available of which, polyvalent antivenom is available in India. 
          In India, Polyvalent antivenom is developed in equines against 
venom of common krait, spectacled cobra, Saw scaled viper, Russells 
viper. It is either in liquid form or lyophilized form which can be 
reconstitute to 10 ml/vial. 
ASV manufacturers in India: 
 Bharat serum and vaccines, Mumbai. 
 Biological E (Evans) limited. 
 VINS Bioproducts Ltd. 
DOSE:  it is calculated according to the average quantity of venom 
milked out from the snakes captured. 
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The dose of antivenom needed to neutralize the effects of venom is 
same in both adults and paediatric age group, since the amount of 
injected venom is similar. 
INDICATIVES FOR ASV: 
FEATURES OF SYSTEMIC ENVENOMING: 
Abnormalities in Hemostasis: Spontaneous bleeding manifestations, 
Signs of coagulopathy,Thrombocytopenia 
Signs of NeutrotoxicEnvenoming:Ptosis, External Opthalmoplegia, 
Respiratory paralysis, Muscle weakness. 
Cardiovascular Abnormalities: Hypotension,Circulatory shock, 
Arrythmias, ECG changes. 
Acute Kidney Injury Manifestations:Oliguria, Elevated blood urea 
nitrogen and serum creatinine levels, Signs of metabolic acidosis, 
Changes in the color of urine. 
Signs Of Hemolysis And Rhabdomyolysis:Muscle aches and pain 
(clinically), Hyperkalemia (laboratory). 
LOCAL ENVENOMING 
 Locall swelling involving more than half of the bitten limb within 
48 hours 
 Rapid extension of welling within a few hours of bite 
 Development of an enlarged tender lymph nodes. 
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 Antivenom treatment can be given even if the patient presents with 
signs of systemic envenoming after several days or with hemostatic 
abnormalities after 2 or more weeks since it can reverse the signs of 
envenoming. 
CONTRAINDICATIONS TO ANTIVENOM 
There is no absolute contraindication to antivenom treatment. People with 
history of allergic reaction to snake venom and those with a strong history 
of atopic diseases are at higher risk. Hence they should be administered 
with antivenom only in case of systemic envenoming 
 
ADMINISTRATION OF INJ. ASV 
Freeze dried form is reconstituted with 10ml of sterile water per vial 
which is administered via the intravenous route either by the intravenous 
push injection or intravenous infusion.Local administration is usually not 
recommended. 
Intravenous push injection:It is an economical method in which the 
antivenom is given by slow intravenous infusion 
Intravenous infusion:The antivenom is diluted in approximately 10 ml of 
normal saline or distilled water. 
The patient must be in observation for at least 1hr so that early 
anaphylaxis can be detected and treated with epinephrine. 
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RESPONSE TO ANTIVENOM 
General signs:Nausea, headache, generalized pain resolving rather 
quickly which may be partly due to placebo effect.Spontaneous bleeding 
manifestations resolves within 15-30 minutes. Hemostatic integrity 
(assessed by 20WBCT) is usually normal within 3-9 hrs. 
Hemodynamic status: in patient in shock, blood pressure rises within the 
first 30-60 minutes. 
Changes In Urine Colour: urine returns to its normal colour since active 
hemolysis and rhabdomyolysis may resolve within few hours. 
Neurotoxic envenoming: In case of post synaptic type, signs usually 
takes several hours, but it may also improve as early as 30 mins, which is 
not same as in the case of presynaptic toxins. 
RECURRENCE OF SYSTEMIC ENVENOMING: 
Systemic envenoming may recur within 24 – 48 hours after an initial 
response to antivenom. This may be due to as a result of improved blood 
supply following correction of hemodynamic abnormalities, there may be 
absorption of venom from the site of bite. Redistribution of venom into 
the vascular space.Indications for repeating the initial dose of 
ASV.Persistence or recurrence of hemostatic abnormality after 6 
hours.Bleeding after 1 – 2 hours.Worsening neurotoxic and cardiovascular 
signs 
ASV REACTIONS:  
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Hypersensitivity reactions: (10 mins – 3 hours) 
Within 10 mins – 3hours of administration of antivenom, patient develops 
itching commonly present over the scalp and urticaria, fever, nausea, 
vomiting, drycough, diarrhoea, abdominal colic and tachycardia.In a few 
cases, the patient may go in for life threatening anaphylaxis, 
bronchospasm, angioedema, hypotension. They are not true allergic 
reaction because there has been no evidence of specific IgE. They are 
mostly due to complement activation by IgG aggregate or due to direct 
stimulation of mast cells by antivenom proteins 
Pyogenic reactions:  (within 1 – 2 hours) 
Patient develops rigors, fever, decline in blood pressure and vasodilation 
which are due to contamination of ASV by pyogens during the 
manufacture 
Late (serum sickness type) reactions: ( after 2 – 12 days) 
Patient presents with features of fever, nausea, itching, recurrent urticaria, 
arthralgia, myalgia, lymphadenopathy, vomiting, diarrhea, periarticular 
swellings, mononeuritis multiplex proteinuria which leads to immune 
complex nephritis and very rarely, the patient may present with 
encephalopathy. 
TREATMENT OF ANTIVENOM REACTIONS: 
Early anaphylactic Reaction: 
Epinephrine :It is the drug of choice. 
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Dose : 0.5 mg  deep intramuscular or Subcutaneous. In case of 
coagulopathy slow IV injection with 1 :10000 dilution can be given. 
ChlorPheniramine  Maleate : 
 It is antihistaminic, should be given immediately after Inj.Epinephrine. 
Dose :10 mg for adults, 0.2 mg/kg for Children. 
Steroids :It is given to prevent late reactions of Type 1  hypersensitivity. 
Hydrocortisone – short and rapidly acting steroid, dose is 100 mg for 
adult, 2mg/kg for Children. 
Pyogenic Reactions : Patient must be treated with tepid sponging and 
antipyretics. 
Late Serum Sickness Reaction: It can be treated with a 5 – day course of 
oral histamines. In case of no response within 24 – 48 hours, patient 
should be treated with 5 day course of oral prednisolone. 
TREATMENT OF THE BITTEN PART : 
The cellulitis should be treated with antibiotics, Serratiopeptidases, 
analgesics and proper Limb elevation. NSAIDS should be avoided, as it 
may cause renal damages. If it is massive, have signs of compartmental 
syndrome, fasciotomy should be done after correcting coagulopathy. 
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SYNDROMIC APPROACH TO SNAKE BITE ENVENOMATION. 
It is controversial now, because the clinical signs and symptoms of snake 
bite envenomation was studied thoroughly with so many research and it is 
not practiced now because of availability of polyvalent antisnake 
venom.Eg: Some elapid snakes like Asian cobra will cause severe local 
envenomation, may be confused with viper envenomation. In India 
Russell’s viper venom sometimes causes both local severe envenomation 
with neurotoxic signs like ptosis, it may be mistakenly taken as Cobra bite 
Envenomation. “Syndromic approach” may be useful, when the bitten 
snake has not been identified and only monospecificantivenoms are 
available and also for statistical purposes. 
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SYNDROMIC APPROACH TO SNAKE BITE ENVENOMATION 
 
Figure 19.Syndromic approach to snake bite envenomation 
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SPECIES IDENTIFICATION 
 
Figure 20. Species identification 
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ACUTE KIDNEY INJURY IN SNAKE BITE 
This is most common in victims of Russell’s viper and some species of 
Bothrops will develop acute injury within hours of bite. Pre Renal as well 
as Renal  injury will occur in snake bite envenomation. 
ANATOMY OF KIDNEYS 
DEFINITION:  kidneys are the pair of organs situated in the retro 
peritoneum. Its main function is to remove the excess water and salts and 
to remove the waste products of metabolism. 
EXTERNALLY – kidney is bean shaped. It has 
 2 poles – the upper pole which is broad and is related to the 
suprarenal gland and the other, lower pole is narrow 
 2 borders – lateral border is concave and medial border is convex, 
through which hilum passes through 
 Hilum – a depression in the medial border gives rise to the hilum 
through which the structures passes  from anterior to posteriorly are 
the renal vein, renal artery and renal pelvis 
 Location – occupies upper border of T12 to middle of L3.   In the 
epigastric, hypochondriac, lumbar and umbilical quadrants.  Right 
kidney is slightly lower than the left 
 Shape – bean shaped 
 Size – 11*6*3 cm 
85 
 
 Weight – 150 g in males and 135 g in females 
COVERINGS OF KIDNEY 
 Fibrous capsule – It is the thin membranous layer covering the 
kidney which can be easily stripped off 
 Perirenal Or PerinephricFat : Next to fibrous capsule there is a layer 
of adipose tissue that constitute the perinephric fat, that are more in 
the borders. It has two layers, anteriorly fascia of Gerota and 
posteriorly, fascia of Zuckerkandal. It is a single multilaminated 
structure that divides at variable point to cover the structures 
 Pararenal Fascia : It consist of fat in varying quantities more in the 
lower poles and posterior surface 
 Importance Of Renal Fascia : Its forms the support for the kidneys. 
If this fat is lost in conditions like extreme fasting, it leads to 
‘kinking of ureters” 
STRUCTURE 
In coronal section, the kidney shows the outer reddish brown cortex, the 
inner pale medulla and the space called the renal sinus. Renal medulla 
forms conical masses called the pyramids, apices form the renal papillae. 
Renal cortex is formed of cortical arches and the renal columns. The space 
that extends into the kidney from hilum called the renal sinus. It contains 
branches of renal artery, renal vein tributaries and renal pelvis. 
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BLOOD SUPPLY 
Arterial supply by renal artery is a branch of abdominal aorta. 
Renal artery divides to anterior and posterior division, which gives rise to 
segmental artery, then to interlobar arteries, which in turn gives rise to 
arcuate artery, this arcuate artery divides to interlobular arteries which are 
end arteries 
MULTIPLE FUNCTIONS OF KIDNEYS 
The main function of kidneys are the excretion of waste products of 
metabolism namely urea, from aminoacid metabolism. Creatinine from the 
muscle creatinine, bilirubin from hemoglobin, they also help in removing 
the toxins from the foreign chemicals, drugs, hormonal metabolites 
It helps in the regulation of water and electrolyte balance, by formation of 
urine, Glomerular filtration, Tubular reabsorption, Tubular secretion. 
 Kidneys play an important role in maintaining acid base balance, 
since only the kidneys excrete few acids like sulphuric acid from 
the protein metabolism. 
 It maintains the arterial pressure by the rennin angiotensin system 
 In production of erythrocytes, by the secretion of hormone called 
erythropoietin, which stimulates the bonemarrow in production of 
RBCS, the main stimuli is hypoxia. 
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PRE RENAL CAUSES FOR ACUTE KIDNEY INJURY : 
 IntravasculsarHypovolemiadue to recurrent vomiting, Fluid 
restriction practiced as a custom in Rural Tamilnadu, accumulation 
of fluid in the bitten limb as massive cellulitis may cause reduced 
plasma flow to Kidney resulted in treatable Pre-AKI. 
 Capillary Leak Syndrome- due increased vascular permeability 
secondary to systemic envenomation may cause third space fluid 
collection and intravascular hypovolemia. 
 Hypovolemia should be corrected with IV crystalloids like Normal 
Saline and Ringer’s Lactate. Central Venous Pressure should be 
monitored, maintained 7-10 cm of water. 
 Sometimes allergic reactions with Antisnake venom, Anaphylaxis 
may cause kidney injury. 
Direct renal injury 
Direct renal injury will occur due to following reasons : Toxic products 
released from intra vascular haemolysis, direct toxicity by venom, 
disseminated intra Vascular Coagulation, Capillary leak syndrome, 
Papillary necrosis and drug induced interstitial nephritis. Patients bitten by 
Russell’s vipers may become oliguric within a few hours of the bite. Loin 
pain and tenderness may be experienced within the first 24 hours and, in 3 
or 4 days, the patient may become irritable and hypertensive and may 
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convulse and become comatose with evidence of metabolic acidosis. 
VasculotoxicityNephrotoxic myotoxicityEndotoxicity 
 
 Intense                          Tubular endothelial                             Complement 
Vasospasm                              injury                                             Activation 
 
Reduced Renal perfusion                                                        Coagulopathy 
 
Ischemia ,ACUTE TUBULAR NECROSIS                  
Intraarterial& 
Intraglomerular Thrombosis 
 
 
CORTICAL NECROSIS 
FLOW CHART : MECHANISM OF RENAL INJURY IN SNAKE BITE 
 
RENAL PATHOLOGY : 
I. Acute tubular necrosis is the commonest lesion associated with 
good prognosis. 
II. Cortical necrosis may be patchy or diffuse. The renal cortical 
necrosis is due to the Schwartzman-like phenomenon
24
. In diffuse 
cortical necrosis renal failure is irreversible and patient needs renal 
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replacement therapy. In patchy cortical necrosis patient may 
continue in chronic renalfailure. 
III. Papillary necrosis has been reported from Calicut. Patients may 
complain of passing tissues in the urine and is associated with colic 
andhaematuria36. 
IV. Tubulo – Intestinalnephritis. 
 Late in onset (after 7 days) 
 Non – Oliguric renal failure detected by biochemicalmonitoring 
 May be due to ASV or other drugs used in themanagement 
 Good prognosis. 
V. Hemorrhagic Glomeruonephritis is very  rare. 
WARNING SIGNS OF ACUTE KIDNEY INJURY 
a) Dwindling or no urine output 
b) Rising blood urea/creatinine concentrations 
 
c) Clinical “URAEMIA SYNDROME”: 
 Nausea, vomiting, 
 Hiccups, fetor, 
 Drowsiness, confusion, coma, 
 Flapping tremor, muscle twitching, convulsions 
 Pericardial friction rub, 
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 Signs of fluid overload. 
STAGING  OF ACUTE KIDNEY INJURY: 
RIFLE AND AKIN STAGING: 
        In 2004, RIFLE – Risk, Injury, Failure and End stage renal disease 
criteria was formed and it defined acute kidney injury based on Serum 
Creatinine, Urine output and GFR.  
Due to some limitations like need for baseline creatinine, Difficulty in 
calculating GFR, in 2007, Acute Kidney Injury Network (AKIN) was 
formed and it was used to define and categorise Acute Renal Injury into 
three groups with hourly urine output with serum creatinine. It can be used 
for AKI of All causes. 
 
Fig. 21). AKIN and RIFLE criteria 
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MANAGEMENT OF AKI : 
    Most of the patients with acute renal failure are oliguric, defined as 
“urineoutput of less than 400 ml/day or less than 20 ml/hour4”.  
Conservative management may be avoided for these patients, the chance 
for need of dialysis is increased in this patients. 
    If the patient has signs of intravascular volume depletion, indicated by 
supine or postural hypotension, or empty neck veins, severe dehydration 
should be proceeded as follows    
A. Establish intravenous access. 
B. Insert a urethral catheter with full sterile precautions 
C. Fluid challenge4: 
 Two litres of isotonic saline over one hour is to be given or the 
fluids to be given until the jugular venous pressure/ central venous 
pressure has risen to 8-10 cm above the sternal angle (with the 
patient propped up at 45º).  
 The patient should be closely observed while this is being done.  
 The fluid challenge should be stopped immediately if pulmonary 
oedema develops. 
 If the urine output does not improve it is reasonable to try a 
Furosamide and/or mannitol challenge, but these are not of proven 
benefit. 
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D. Furosemide (frusemide) challenge: 100 mg of furosemide is 
injected slowly (4-5 mg/minute). If this does not induce a urine 
output of 40 ml/hour, give a second dose of furosemide of 200 mg. 
If urine output does not improve, try conservative management4.    
E. Conservative management: 
 If the urine output is not improving, despite these challenges, no 
further diuretics should be given and fluid intake should be 
restricted to a total of the previous day’s output plus “insensible 
losses” (500-1000 ml/day).  
 The patient should be referred to a renal unit.  
 The diet should be bland, high on calories (1700/day), low in 
protein (less than 40g/day), low in potassium (avoid fruit, fruit 
juices and potassium-containing drugs) and low in salt. 
 Infections will cause tissue breakdown and increase urea levels. 
They should be prevented or treated promptly with non-nephrotoxic 
antibiotics (i.e. avoid aminoglycosides such as gentamicin)13. 
F. Biochemical monitoring: Serum potassium, urea, creatinine and, if 
possible, pH, bicarbonate, calcium and phosphate should be 
monitored frequently. 
G. Management of complications : 
1. Metabolic acidosis : If the patient is hypotensive and profoundly 
acidotic (deep sighing “Kussmaul” respirations, very low plasma 
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bicarbonate concentration or very low pH - <7.10), sodium 
bicarbonate should be given. It should be based on volume of 
distribution of bicarbonate which is 50% of body weight, 
bicarbonate deficit can be calculated. 
2. Hyperkalemia: Plasma potassium should be monitored. 
Hyperkalemia should be managed promptly according to the 
severity with calcium gluconate, Beta agonists, Insulin with 
Dextrose infusion, potassium binders etc53. 
 
3. Dialysis : 
Indications for Dialysis : 
 Clinical uraemia 
 Fluid overload 
 Blood biochemistry-one or more of the following 
 Potassium >7 mmol/l (or hyperkalaemic ECG changes) 
 Symptomatic acidosis 
Prevention of renal damage in patients with Myoglobinuria or 
Haemoglobinuria : 
 It is done to minimize the risk of renal damage from excreted 
myoglobin and/or Haemoglobin. 
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 Correction of hypovolaemia and maintain saline diuresis (if 
possible) 
 Correction of severe acidosis with bicarbonate. 
 Mannitol infusion :Give a single infusion of mannitol (200 ml of 
20% solution over 20 minutes)(not of proven benefit) 
Management of Diuretic phase of kidney injury 
       This is as important and as life-threatening as the oliguric phase. 
Urine output increases to 5-10 litres/24 hours following the period of 
anuria. The patient may become polyuric and volume depleted so that salt 
and water must be carefully replaced. Hypokalaemia may develop, in 
which case a diet rich in potassium (fruit and fruit juices) is recommended. 
Management of Renal recovery phase : 
     The diuretic phase may last for months after Russell’s viper bite. In 
Myanmar and South India, hypopituitarism may complicate recovery of 
Russell’s viper bite victims. Corticosteroid, fluid and electrolyte 
replacement may be needed in these patients. 
Persisting renal dysfunction: 
Persistent tubular degenerative changes were observed in patients with 
Russell’s viper bite,  who will be continuing to have albuminuria, 
hypertension and nocturia for up to 11 months after the bite, despite 
apparent recovery in renal function.  
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In India, 20%-25% of patients referred to renal units with acute renal 
failure following Russell’s viper bite suffered oliguria for more than four 
weeks suggesting the possibility of bilateral renal cortical necrosis. This 
can be confirmed by renal biopsy or contrast enhanced CT scans of the 
kidneys, non invasive CT-KUB is better than Renal biopsy.  
Patients with patchy cortical necrosis show delayed and partial recovery of 
renal function but those with diffuse cortical necrosis require regular 
maintenance dialysis and eventual renal transplantation. 
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METHODOLOGY 
           This study was done at Govt. Mohan Kumaramangalam Medical 
college hospital, Salem during a period betweenApril 2015 to March 
2016.This is a Prospective and observational study which had a sample 
size of 100 patients 
SOURCE OF DATA 
           The study group included 100 patients admitted to GMKMC Salem 
with history of snake bite and who satisfied inclusion and exclusion 
criteria. 
METHOD OF COLLECTION OF DATA 
           Patients were evaluated by taking a detailed history, clinical 
examination and laboratory investigations. A proforma was specially 
designed for data collection including all these.  
INCLUSION CRITERIA 
1.History of Snake bite with signs of Envenomation 
2. Progressive elevation of serum creatinine>0.3mg/dl from baseline, a 
percentage increase in the serum creatinine concentration of >50% or 
oliguria of less than 0.5ml/kg/hr for more than 6hrs. 
3. Age is more than 18 years. 
EXCLUSION CRITERIA 
1.Patients with Pre existing Renal Diseases with history of Snake bite. 
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2. Extreme age groups - age more than 80 years 
3.Patients with contracted kidneys with normal Renal Parameters with 
history of Snake bite. 
All patients were subjected to the following investigations 
 Hb, 
 PCV 
 Platelets  
 Urine complete 
 Blood Urea, Serum creatinine, 
 USG abdomen & Pelvis 
 ECG 
PROCEDURE IN DETAIL : 
      Patients admitted in Emergency Room, GMKMCH with history of 
Snake bite were taken into the study. Some of the patients were 
initially treated in some hospitals and referred to our hospital with 
Acute Kidney injury also taken. Details regarding initial treatment, 
renal parameters have been collected. 
         Acute kidney injury was defined according to AKIN criteria. 
Patients were classified into 4 groups- NO AKI, AKIN 1, AKIN 2, 
AKIN 3 by monitoring urine output Hourly and Serum Creatinine. 
Patients were followed up from admission to discharge. If patients 
developed acute kidney injury means, they were transferred to 
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Nephrology ward and continuous monitoring was done. CBC- Hb, 
PCV, and Platelet count was monitored daily. Renal parameters 
monitored twice daily. Patients were followed up till discharge. 
STATISICAL ANALYSIS  
      The study design was a prospective non interventional observational 
study. All data collected were noted using a structured proforma, 
including the investigations. Data was analysed using statistical package 
and SPSS structured software to find out the proportion of acute kidney 
injury among 100 patients, and their clinical profile and outcome of them.  
FUNDING AGENCY: None. 
ETHICAL CONCERNS: As per the institution protocol.  
CONSENT: Informed consent was taken as per standard procedure that is 
followed in the institution. 
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OBSERVATIONS & RESULTS 
The study was prospective, observational, non- interventional and follow 
up study. 100 patients were selected randomly who fulfils the criteria for 
the study. Following parameters were observed in our study. 
1).GENDER WISE DISTRIBUTION OF PATIENTS   
 
 
 
 
Table .2.Gender wise distribution of patients   
 
22. GENDER WISE DISTRIBUTION OF PATIENTS   
In total number of patients observed in our study is 100. Among them 56 
patients are male and 44 patients are female.  Most of the patients from 
rural areas of Salem district and nearby districts – Namakkal, Erode, 
Dharmapuri, Krishnagiri, Villupuram and Trichy. 
 
[VALU
E] %
56 %
PATIENT DISTRIBUTION 
FEMALE MALE
Gender No. Of patients Percentage 
Male 56 56 % 
Female 44 44% 
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1.GENDER WISE TABLE WITH RURAL AND URBAN 
PATIENTS. 
Table  3).Gender wise table with rural and urban patients. 
 
23).GENDER WISE TABLE WITH RURAL AND URBAN 
PATIENTS. 
 Most of the patients from rural areas, all are related to agriculture as 
farmers, relatives of agricultural workers, field workers etc. Both male and 
female patients were almost equal in our study. 
         In patients from urban areas, they have been exposed to snake while 
travelling or roadside, or living in slum areas etc. Among 8 patients from 
urban area, 5 were male and 3 were female. They reached the hospital 
within 1hr and the outcome was good 
92%
8%
RURAL Vs URBAN 
rural 
urban 
Gender  Rural  Urban  
Male  50 6 
Female  42 2 
Total 92 8 
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3). AGE GROUP DISTRIBUTION WITH GENDER 
 
 
Table no. 4). Age group distribution with gender 
 
24). AGE GROUP DISTRIBUTION WITH GENDER 
 
Most of the patient in both sex groups are in between 30-60 years, only 
few patients are in more than 60 years of age. Most of the patients do not 
have any co-morbidities. Mean age is 41 years with minimum age of 18 
years and maximum age of 80 years 
0
5
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35
MALE FEMALE
AGE GROUP DISTIBUTION
<30 YRS 30-60 YRS >60 YRS
Gender <30 years 30-60 years >60 years 
Male 18 30 8 
Female 13 25 6 
Total 31 55 14 
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4). SITE OF BITE WITH GENDER 
 
 
 
 
Table no.5). Site of bite with gender 
 
25). SITE OF BITE WITH GENDER 
     Right lower limb is the commonest site of bite in both sex groups. Bite 
in the hand occurred in patients working in the field particularly 
agricultural workers. Some of the patients had been bitten over shoulder, 
thigh and one patient had been bitten over the face. As most of them are 
field workers, bare foot walkers, dorsum of foot and ankle were the most 
common areas of bite. 
 
0
10
20
30
40
50
60
LOWER LIMB UPPER LIMB
SITE OF BITE
RIGHT LEFT
Site of bite Right Left Total 
Foot 51 32 83 
Hand 13 4 17 
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5). PATIENTS WITH CO MORBIDITIES : 
 
 
 
Table 
no.6).P
atients with co morbidities. 
 
26). PATIENTS WITH CO MORBIDITIES. 
Most of the patients in our study do not have any co-morbidities. 92% of 
patients in our study were not having any co-morbidities. One patients was 
HIV positive, not on art. One patient was both hypertensive and diabetic. 
5 patients are hypertensives on regular anti-hypertensive drugs and 
hypertension was under control. 
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MALE FEMALE
Patients with co morbidities 
SHT DM OTHERS NO COMORBITIES
GENDER SHT DM OTHERS 
Male 1 0 1 
Female 5 1 0 
Total 6 1 1 
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6). CELLULITIS IN OUR PATIENTS. 
 
 
 
 
Table no.7).Cellulitis in our patients. 
 
27). GENDER WISE CELLULITIS DISTRIBUTION 
Cellulitis is more common with male, corresponds to 62 % in total 
cellulitis. In my study 56 male patients were admitted, among them 45 
(80%) patients developed cellulitis. In female patients 28/44 which is 
64%. Development of cellulitis is depend upon the species of snake bites, 
and potency of the venom and  not depends upon the limbs. But 
progression of cellulitis is depends upon the effective treatment given. 
 
CELLULITIS
WITHOUT CELLULITIS
0
50
MALE FEMALE
45
2811
16
Cellulitis in our patients
CELLULITIS WITHOUT CELLULITIS
Gender Cellulitis Without cellulitis 
Male 45 11 
Female 28 16 
Total 73 27 
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7).REGIONAL LYMPHADENOPATHY  AND CELLULITIS IN 
RELATION TO GENDER: 
Gender  Lymphadenopathy  Cellulitis  Both  
Male  42 45 39 
Female  26 28 19 
Total  68 73 58 
Table no. 8).Regional lymphadenopathy and cellulitis in relation to gender 
 
28).REGIONAL LYMPHADENOPATHY  AND CELLULITIS IN RELATION 
TO GENDER: 
Cellulitis is sign of local envenomation of some snake species, occurred 
more in males (45/56 =80%) than females (28/44=64%). Lymhadenopathy 
is also more common in male patients (42/56 =75%) compared with 
(26/44 =59%). Both of them are signs of local envenomation, both was 
present in 39 male patients and 19 female patients. Hence most of the 
patients are having both cellulitis and lymphadenopathy in our study. 
0
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Male Female
CELLULITIS AND LYMPHADENOPATHY IN OUR 
PATIENTS
Lymphadenopathy Cellulitis Both
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8).RELATION OF BITE- TO NEEDLE TIME WITH ACUTE 
KIDNEY INJURY: 
Bite to 
needle 
time 
NO 
AKI 
AKIN 
1 
AKIN 
2 
AKIN 
3 
Total Chi 
square 
P 
< 6 hrs 52 11 4 17 84 15.166 
Df- 2 
0.0005 
 6 – 12 
hrs 
4 1 2 4 11 
>12 hrs 0 0 1 4 5 
Table No. 9) : Bite to needle time in relation to AKIN staging 
 
AKIN 
staging 
Bite to needle time Total Chi 
square 
P 
<1 
hr 
1-2 
hrs 
2-3 
hrs 
3-4 
hrs 
4-5 
hrs 
5-6 
hrs 
N % N % N % N % N % N % 
NO 
AKI 
1
9 
3
8 
1
7 
3
1 
9 1
8 
3 6 2 4 0 0 50 18.329 
Df-15 
0.045 
AKIN1 4 3
6 
3 2
8 
2 1
8 
2 1
8 
0 0 0 0 11 
AKIN2 0 0 2 5
0 
2 5
0 
0 0 0 0 0 0 4 
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AKIN3 5 3
1 
6 3
8 
1 6 1 6 2 1
3 
2 6 16 
Total 2
8 
3
4 
2
8 
3
4 
1
4 
1
8 
6 7 4 5 2 2 82 
Table  No.10). Bite to needle time (less than 6 hours) related to AKIN 
staging. 
       82 patients were admitted in hospital before 6 hours, among them 50 
patients did not develop AKI. 11 patients developed AKIN 1 and 4 
patients developed AKIN 2 and 17 patients developed akin 3. Among 
patients admitted before 6 hours, 28 patients admitted immediately within 
one hour, among them 19 didn’t develop AKI, but 5 people developed 
akin 3. In 6-12 hours group, 5 people didn’t develop AKI, but 5 peoples 
developed akin3. In more than 12 hours group, all developed severe AKI. 
Among 5 people, 4 developed stage 3 AKI and one developed stage 2 
AKI.  
So early admission sometimes may not prevent development of AKI. But 
delay in admission is definitely resulted in bad prognosis, sometimes 
death may occur in those patients. 
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29).BITE TO NEEDLE TIME IN RELATION TO AKIN STAGING 
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LESS THAN 6 HRS 6- 12 HRS MORE THAN 12 HRS
BITE TO NEEDLE TIME TO AKI
AKIN 0 AKIN 1 AKIN 2 AKIN 3
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9).CO MORBIDITIES OF PATIENTS RELATED TO STAGING OF 
AKI 
Table no. 11).Co morbidities of patients related to staging of AKI 
 
30).CO MORBIDITIES OF PATIENTS RELATED TO STAGING OF AKI  
            Most of the patients in our study were not having any co 
morbidities. 8 patients had comorbidities like SHT,DM. It plays an 
important role in development of AKI. Among 8 patients, 6 patients 
0
10
20
30
40
50
60
NO CO MORBITIES SHT SHT/DM OTHERS
CO-MORBIDITIES WITH AKIN STAGING
AKIN O AKIN 1 AKIN 2 AKIN 3
Comorbiditi
es 
NO 
AKI 
AKIN 
1 
AKIN 
2 
AKIN 
3 
Total Chi 
square 
test 
P 
value 
Without co 
morbidities 
54 12 6 20 92 22.767 
Df-9 
0.007 
SHT  2 0 0 4 6 
SHT/DM 0 0 0 1 1 
Others 0 0 1 0 1 
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developed severe AKI. Eventhough patients with co-morbidities were only 
few in number, significant association is noted. 
10).CELLULITIS IN  PATIENTS RELATED TO STAGING OF 
AKI : 
 Table No. 12).Cellulitis in  patients related to staging of AKI 
         Among 56 patients in no AKI group, 32 patients (58%) had cellulitis 
and 24 patients (42%) didn’t have cellulitis. 25 patients in akin3 group, 
only one  patient (4%) didn’t have cellulitis. This association is significant 
as p value is <0.05. AKI can be expected in patients with severe cellulitis. 
Accumulation of litres of fluid into the bitten limb as cellulitis may be one 
of the reason for pre-renal AKI in this group. 
Cellulitis NO 
AKI 
AKIN 
1 
AKIN 
2 
AKIN 
3 
Total Chi 
square 
tests 
P 
value 
With 
cellulitis 
32 10 7 24 73 7.097 
Df-2 
0.028 
Without 
cellulitis 
24 2 0 1 27 
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31).CELLULITIS IN  PATIENTS RELATED TO STAGING OF AKI  
 
11.PROTEINURIA WITH AKIN STAGING : 
Table no.13). Proteinuria with AKIN staging 
Proteinuria is a sign of renal injury. It was occurred in 37 % of patients. 3 
% of patients without AKI also developed proteinuria. But in most of the 
AKI patients, proteinuria is bad sign of outcome. 4+ proteinuria was 
A K I N  0 A K I N  1 A K I N  2 A K I N  3
32
10 7
24
24
2 0
1
CELLULITIS WITH AKIN STAGING
WITH CELLULITIS WITHOUT CELLULITIS
Albuminuria NO 
AKI 
AKIN 1 AKIN 2 AKIN 3 Total Chi 
square 
test 
P value 
0 53 6 2 2 63 74.807 
Df-12 
0.000 
1 1 2 0 4 7 
2 2 3 1 3 9 
3 0 0 1 3 4 
4 0 1 3 13 17 
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present in 13 patients and 2 patients  did not have proteinuria. It is one of 
the early predictor of AKI and prognosis. If heavy proteinuria is present, 
renal injury also is more. 
 
32)..PROTEINURIA WITH AKIN STAGING 
 
12.THROMBOCYTOPENIA WITH AKIN STAGING 
Table no.14).Thrombocytopenia  with AKIN staging 
0
10
20
30
40
50
60
NIL ALBUMINURIA 1 + ALBUMINURIA 2 + ALBUMINURIA 3+ ALBUMINURIA 4 + ALBUMINURIA
ALBUMINURIA WITH AKIN STAGING
AKIN 0 AKIN 1 AKIN2 AKIN 3
PLC AKIN 0 AKIN 1 AKIN2 AKIN 3 Chi 
square 
test 
P value 
<0.5L 0 0 3 11 73.856 
Df-9 
000 
0.5 – 1 L 0 0 2 8 
1– 1.5 L 2 2 1 2 
>1.5L 54 10 1 4 
114 
 
 
33).THROMBOCYTOPENIA WITH AKIN STAGING 
Thrombocytopenia was present in almost all patients with AKI. In AKIN 
0 group, only 2 patients had mild thrombocytopenia in the range of 1 – 1.5 
lakh/mm3. In AKIN 3 group, 21/25 patients (84%) had thrombocytopenia, 
among them 44% of patients had very severe thrombocytopenia. In AKIN 
stage 2, very severe thrombocytopenia was occurred in 3 patients among 8 
patients. Hence thrombocytopenia canbetaken as a marker to predict 
severity of AKI. Also thrombocytopenia is directly proportional to 
severity of AKI in our study. 
13).AKIN STAGING IN RELATION TO NUMBER OF VIALS 
REQUIRED TO NEUTRALISE VENOM(CLINICALLY): 
0
20
40
60
LESS THAN 50000 50000- 100000 1L – 1.5 L MORE THAN 1.5L
THROMBOCYTOPENIA WITH AKI STAGING
AKIN 0 AKIN 1 AKIN2 AKIN 3
ASV 
Vials 
NO 
AKI 
AKIN 
1 
AKIN
2 
AKIN
3 
Total Chi square 
test 
P value 
<8 25 0 1 3 29 19.127 
Df-6 
0.0039
5 8-16 10 4 2 3 19 
>16 22 7 4 19 52 
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 Table no. 15). No. Of ASV vials required to neutralise Venom Clinically 
 
34).AKIN STAGING IN RELATION TO NUMBER OF VIALS REQUIRED TO 
NEUTRALISE VENOM(CLINICALLY): 
        In patient who required less than 8 vials group, only 4 people(13%) 
developed AKI. Inj.ASV was not needed to be repeated in these patients. 
It is sign of mild-moderate envenomation.in patient required to be repeat 
the ASV of once, 10 patients didn’t develop AKI and 9 patients developed 
AKI. It is a sign of moderate to severe envenomation. In third group, 
patient required high amount of ASV, 30 patients among 52 means 58% 
developed severe AKI. Maximum ASV vials given in these patient was 33 
vials.   
14). MANAGEMENT RELATED TO AKIN STAGING : 
26
10
22
0 4 71 2 43 3
19
0
5
10
15
20
25
30
<8 VIALS 8 TO 16 VIALS >16 VIALS
ASV VIALS WITH AKIN STAGING
AKIN 0 AKIN 1 AKIN 2 AKIN 3
Management NO 
AKI 
AKI
N 1 
AKI
N 2 
AKI
N 3 
Total Chi-
square 
tests 
P 
value 
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Table no.16). Management of AKI in relation to AKIN Staging 
In our study among 100 patients, 44 patients developed acute kidney 
injury. Among them 12 patients are in akin 1 stage and all patients 
recovered completely without any complications, not required dialysis. 7 
patients developed akin stage 2, among them Only one patient required 
dialysis and that patients also recovered completely. 25 patients developed 
akin stage 3. Most of the patient, 72% patient required dialysis and some 
of them died inspite of dialysis and effective management. Late 
presentation may be one of the reason for worst prognosis. 
 
35). MANAGEMENT RELATED TO AKIN STAGING  
 
 
 
56
012 05 27
18
0
10
20
30
40
50
60
CONSERVATIVE MANAGEMENT DIALYSIS
MANAGEMENT OF AKI
AKIN 0 AKIN 1 AKIN 2 AKIN 3
Conservative 56 12 5 7 80 60.926 
Df-6 
0.000 
Dialysis 0 0 2 18 20 
Total 56 12 7 25 100 
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15.OUTCOME OF PATIENTS WITH AKIN STAGING : 
Table no 17). Outcome of patients in various AKIN group 
In our study, 44 patients developed AKI. 90 % of patients recovered 
completely. 12 patients with AKIN 1, 6 patients with AKIN2, 15 patients 
with akin3 recovered with conservative management. 6 patients become 
dialysis dependant and 4 patient died, all of them are in stage3 AKIN. 
 
36).OUTCOME RELATED TO AKIN STAGING : 
0
10
20
30
40
50
60
AKIN 0 AKIN 1 AKIN 2 AKIN 3
OUTCOME OF PATIENTS WITH AKIN STAGING
COMPLETE RECOVERY DIALYSIS DEPENDANT DEATH
Management AKIN 
0 
AKIN 
1 
AKIN 
2 
AKIN 
3 
Total Chi-
square 
tests 
P 
value 
Complete 
recovery 
56 12 7 15 90 26.847 
Df-6 
0.000 
Dialysis 
dependant 
0 0 0 6 6 
Death 0 0 0 4 4 
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16. BITE TO NEEDLE TIME TO RECOVERY : 
Table no.18). Recovery of patient in relation to bite to needle time 
 
          90 patients in our study recovered completely. Among them 78  
patients were admitted before 6  hours, 10 out 11 patients in category 2 
admitted in 6 – 12 hours recovered. In more than 12 hours group,  2 
patient recovered completely, 2 become dialysis dependant and one 
patient inspite of dialysis. Biopsy was done in both dialysis 
dependantpatient. Both the patients developed patchy cortical necrosis. 
Out come Complete 
recovery 
Dialysis 
dependant 
Death Chi square 
test 
P value 
Lees than 6 
hrs 
78 3 3 14.306 
df -4 
0.00637 
<0.05 
6 to 12 hrs 10 1 0 
More than 
12 hrs 
2 2 1 
Total 90 6 4 
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37). BITE TO NEEDLE TIME TO RECOVERY . 
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DISCUSSION 
In our study, 100 patients admitted with poisonous snake bites with 
features of envenomation. Various parameters were observed and 
stratified into groups and followed up till discharge. 
GENDER VARIATION WITH SNAKE BITE : 
          In our study, 56 patients were male and 44 patients were female. 
Male population is more than female since most of the outdoor activities, 
farming, field works are done by Males usually. In 1992, 14Hati AK et al, 
have done one epidemiological survey snake bite in the district of the 
Burdwan, West Bengal. In that study 54.27% were male patients and 
45.23% were female patients. 
     92% of patients from rural areas of Salem and surrounding districts 
were admitted. Gender distribution was maintained in that 
papulation.Only 8% peoples are from urban area. 
AGE GROUP DISTRIBUTION : 
       Most of the patients are in 30 to 60 years of age. Maximum age was 
taken into my study was 80 years. Most of the patients were young adult 
patients, active farmers in rural Tamilnadu. To avoid age related changes 
in the Kidney (GFR changes) extreme age group population was not taken 
into the study. 
 In 2006 to 2008, 61Chattopadhyay et al did a study about snake bite in same 
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district mentioned above where snake bites are more common. In that 
study,Patients in the age group of 21-40 years contributed to nearly 60 % 
of total population and among them 60.47% are male patients.  
SNAKE IDENTIFICATION : 
       Most of the patients (60%) have not identified the snake. Few victims 
brought the snake to the hospital and most of the patients were not able to 
differentiate Viper. 5 patients admitted with history of cobra bite with 
typical features and required ventilator and recovered completely and 
didn’t develop AKI. One patient with krait bite was not taken into the 
study, because of presence of pre-existing renal disease. Most of the 
patients had signs and symptoms of Russell Viper bite envenomation.  
COMMON SITES OF SNAKE BITE : 
Lower limbs are commonest sites of snake bite in our study, particularly 
Right Lower Limb. Most of them are agricultural workers, used to work 
with bare foot, used to walk over the grasses. Hence dorsum of foot is the 
most common site of bite followed lower 1/3 of leg. Bite over the dorsum 
of hand also common in these patients.Few patients had bite over the 
thigh, back, shoulder and over the face in one patient, these patients have 
been bitten while sleeping in the ground. 
INCIDENCE OF ACUTE KIDNEY INJURY : 
In our study among 100 randomly selected snake bite patients with 
features of Systemic envenomation, 44 patients developed Acute Kidney 
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Injury. It is just a proportion of Acute Kidney Injury among 100 patients 
in our Hospital.  
CO-MORBIDITIES IN PATIENTS: 
 Only few patients were with comorbidities in our study. Among 8 
patients, 6 patients had hypertension, one patient had hypertension and 
diabetes, one patient was HIV positive on Pre-ART. Other co morbidities 
were not taken into the study.most of the patients (92%) were not having 
any co morbidities. Among 8 patients, 6 people developed severe Acute 
Kidney Injury (AKIN2, AKIN3). 4 patients required dialysis and 3 
patients become dialysis dependant, because development of patchy 
cortical necrosis, which was proven by renal biopsy. No death was 
occurred in these group. 
59Maulita P Kapadia et al conducted one study regarding acute kidney 
injury of all causes with co-morbidities. In that study, more than 50% of 
patients with co-morbidities developed AKI. 
CELLULITIS IN RELATION TO DEVELOPMENT OF ACUTE 
KIDNEY INJURY: 
          Cellulitis is more common with male, corresponds to 62 % in total 
cellulitis. In our study 56 male patients were admitted, among them 80% 
patients developed cellulitis. 64% female patients developed 
cellulitis.Development of cellulitis is depend upon the species of snake 
bites, and potency of the venom and not depends upon the limbs. But 
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progression of cellulitis is depends upon theeffective treatment given. In 
our study species specific snake bite patients were not taken, so it included 
pure neurotoxic snake bite patients also. 
AKI can be expected in patients with severe cellulitis. Accumulation of 
litres of fluid into the bitten limb as massive cellulitis may be one of the 
reason for pre-renal AKI in this group14. 
Rapidly progressive cellulitis one of the indication for repeating the initial 
dose of Inj.ASV. Secondary bacterial infection, tissue necrosis, 
compartmental syndrome, vascular occlusion worsen the development of 
AKI and outcome by releasing inflammatory products and toxins, all 
damages renal vascular endothelium60. 
Athappan et al : “Regional lymphadenopathy was another significant 
independent factor for ARF. Just as cellulitis, Regional lymphadenopathy 
can be a bedside indicator of the amount of toxin released by the snake 
bite”9. 
 
CELLULITIS AND LYMPHADENOPATHY RELATED TO 
ACUTE KIDNEY INJURY: 
      Both of them are signs of severe local envenomation, both was present 
in 39 male patients and 19 female patients. Hence most of the patients are 
having both cellulitis and lymphadenopathy in our study. It is a sign of 
Viper bite also. 22 /58 (38%) of patients in these group developed stage 3 
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AKI, with heavy proteinuria, and more than 80% required dialysis and 5 
patients become dialysis dependant and 4 patient died of AKI 
complications. In 2013, 22Mrudul V Dharod et al done a study and 
concluded that “92% patients with AKI had moderate to severe cellulitis. 
On the other hand, only about 55% patients without AKI had moderate to 
severe cellulitis”. 
   Rapidly progressive cellulitis with lymphadenopathy is one of the early 
predicting sign of AKI and outcome. It is directly proportional to amount 
and potency of venom. 
PROLONGED COAGULOPATHY WITH ACUTE KIDNEY 
INJURY: 
      In our hospital we are following this method to start Inj.ASV and to 
monitor along with local envenomation signs. In our study, more than 
80% had prolonged clotting time and few patients had only local signs of 
envenomation. In Nearly 20 % , clotting abnormalities were not reversed 
with In.ASV alone, required blood products like FFP, Whole Blood. Few 
patients had hematuria, hematemesis and 1 patient had 
intracerebralhaemorrhage and died. 
        Acute kidney injury was not developed in patients with normal 
Clotting time. So it can be taken as risk factor for AKI. 
           “101 (59.06%) snakebite patients were presented with 20 min 
WBCT > 20 min and of which 55 (54.45%) patients were suffering from 
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AKI” - (Jayanta Paul et al )59. 
BITE TO NEEDLE TIME AND DEVELOPMENT OF ACUTE 
KIDNEY INJURY : 
    82 patients were admitted in hospital before 6 hours, among them 50 
patients did not develop AKI, 11 patients developed AKIN 1 and 4 
patients developed AKIN 2 and 17 patients developed AKIN 3. 
Among patients admitted before 6 hours, 28 patients admitted 
immediately within one hour, among them 19 didn’t develop AKI, but 5 
people developed AKIN 3. In 6-12 hours group, 5 people didn’t develop 
AKI, but 5 peoples developed akin3.  
       In more than 12 hours group, all developed severe AKI. Among 5 
people, 4 developed stage 3 AKI and one developed stage 2 AKI.  
  In 2012, Jayantapaul et al have done small study in Gujarat, Mean time 
in between snakebite and administration of ASV (minutes) 110.22 ± 7.60 
was observed and mean patients developed acute kidney injury is 66.39 ± 
4.3659.  
Suchithra N et al. stated in their study of Snakebite envenoming in Kerala, 
South India; “ Those who received ASV early (bite to needle time < 6hrs) 
had more severe local envenoming than those who received ASV late (bite 
to needle time > 6 hrs), but latter group were more likely to suffer 
complication and those who received ASV late had a higher risk of 
developing acute renal failure”48.  
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Sharma et al.stated that median bite to hospital time was 9 hrs and delayed 
in admission was more prone to develop acute kidney injury. 
Narvencar K et al  found that Correlation between early administration of 
anti snake venom was beneficial in preventing development of acute 
kidney injury,  however severe was the systemic envenomation46.      
    ” Early administration of antivenom has been demonstrated to 
completely reverse all clinical manifestations of snake envenomation. But 
some studies stated that the early administration of Inj.ASV cannot be too 
strongly emphasized to prevent development of AKI in snakebite 
patients.” – UM.Natarajan et al , SJAMS42. 
So early admission sometimes may not prevent development of AKI. But 
delay in admission is definitely resulted in bad prognosis, sometimes 
death may occur in those patients. 
THROMBOCYTOPENIA AND ALBUMINURIA WITH AKIN 
STAGING AND OUTCOME: 
Thrombocytopenia & albuminuria was present in almost all patients with 
AKI.  
      In AKIN 0 group, only 2 patients had mild thrombocytopenia and in 
AKIN 3 group, 21/25 patients (84%) had thrombocytopenia, among them 
44% of patients had very severe thrombocytopenia. In AKIN stage 2, very 
severe thrombocytopenia was occurred in 3 patients among 8 patients. 
       Hence thrombocytopenia can be taken as a marker to predict severity 
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of AKI. Also thrombocytopenia is directly proportional to severity of AKI 
in our study. 4+ proteinuria was present in 13 patients, all developed 
AKIN stage 3, required dialysis and 4 become dialysis de It is one of the 
early predictor of AKI and prognosis. If heavy proteinuria is present, renal 
injury also is more. 
 
ASV VIALS REQUIRED TO NEUTRALISE IN RELATION TO 
AKIN STAGING: 
        In patient who required less than 8 vials group, only 13% developed 
AKI. Inj.ASV was not needed to be repeated in these patients, it is sign of 
mild-moderate envenomation. 
      In patient required to be repeat the ASV of once, 10 patients didn’t 
develop AKI and 9 patients developed AKI, it is a sign of moderate to 
severe envenomation.  
      In third group, patient required high amount of ASV, 30 patients 
among 52 means 58% developed severe AKI.     
  Some patients required blood products like FFP, Whole blood in addition 
to Inj.ASV. Maximum ASV vials given in these patient was 33 vials. All 
patients required blood products developed AKI. 
INTERVENTIONS NEEDED RELATED TO AKIN STAGING : 
        In our study among 100 patients, 44 patients developed acute kidney 
injury. Among them 12 patients are in AKIN 1 stage and all patients 
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recovered completely without any complications, not required dialysis. 7 
patients developed AKIN stage 2, among them only one patient required 
dialysis and that patients also recovered completely. 25 patients developed 
AKIN stage 3. Most of the patient, 72% patient required dialysis and some 
of them died in spite of dialysis and effective management. Late 
presentation may be one of the reason for worst prognosis. 
       Acute tubule interstitial necrosis is the most common cause acute 
kidney injury. It will recover completely, if treated promptly. It will 
recover over the period of 2 weeks. If it was not recovered even after 2 
weeks, with oliguria, cortical necrosis should be suspected and it is one of 
the indication for renal biopsy12. Some of the patient with patchy cortical 
necrosis will recover completely, but they are more prone to develop 
Chronic Kidney Disease over the period of years. 
    Diffuse cortical necrosis is having worst prognosis, patient will become 
dialysis dependant, will require Renal transplant12. 
OUTCOME OF PATIENT : 
In our study, 44 patients developed AKI. 90 % of patients recovered 
completely. 12 patients with AKIN 1, 6 patients with AKIN2, 15 patients 
with AKIN 3 recovered with conservative management. 6 patients become 
dialysis dependantfor more than a month and among them 3 developed 
diffuse cortical necrosis (Biopsy proven) and progressed to chronic 
Kidney Disease with Dialysis Dependant. 3 patients were discharged with 
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partial recovery and advised to monitor renal parameters regularly and 4 
patient died in hospital, all of them are in stage3 AKIN. 
    Snake species, seasonal variation, bite to needle time, bleeding 
complications, and co-morbidities, extend of cellulitis, lymphadenopathy, 
prolonged clotting time not reversed with ASV alone, hypotension, 
thrombocytopenia, and proteinuria are plays an important role in the 
outcome and complications of snake bite envenomation. 
 Early administration of Inj.ASV, adequate hydration, management of 
Cellulitis are the important factors for good outcome9. 
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CONCLUSION 
 Delay in admission to Hospital is strongly correlated with 
development severe acute kidney injury. 
 Patients with co-morbidities should be monitored carefully, as they 
are more prone to develop AKI and if develops, outcome is poor. 
 Rapidly progressing massive cellulitis and severe coagulopathy are 
signs of severe envenomation. 
 Thrombocytopenia and Proteinuria is strongly correlated with poor 
outcome. 
 Hourly Urine output and serial Renal parameters, ABG should be 
monitored. 
 AKIN staging can be used for early diagnosis, management, to 
predict outcome and prognosis. 
 Prompt treatment of snake bite envenomation may prevent 
development of Acute Kidney Injury in young Healthy Working 
Population and is a preventable morbidity and mortality. 
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LIMITATIONS 
OF THE 
STUDY 
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LIMITATIONS OF OUR STUDY 
 
1) Total Number of patients were taken into our study is small and only 
magnitude of Acute kidney injury occurred among 100 patients was 
calculated. 
 
2) Incidence was calculated in our study is just a proportion of Acute 
Kidney Injury among snake bite envenomation patient in our Hospital. 
 
3) Confirmation of species was not done, as most of them were not 
identified the Snake. Only few people told the name of the Snake. 
 
4) The study was being conducted in a tertiary care centre, many of the 
patients presented as referred cases with a variety of complications of 
Snake bite, thereby increasing the number of incidence and major 
adverse renal outcomes – Berkson’s selection bias.  
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SUMMARY 
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 SUMMARY  
          This study was conducted in Government Mohan Kumaramangalam 
Medical College Hospital, Salem with study population 100, with aim to 
find incidence of acute kidney injury in patients with signs and symptoms 
of envenomation. 
Information regarding circumstances of bite, species of snake, first aid, 
initial management, delay in reaching the hospital, co-morbidities were 
collected and vital signs, 20 mins WBCT, Basic Renal Parameters, 
Complete Hemogram, Urine Routine and thorough examination of local 
site of envenomation and features of systemic envenomation noted. 
    Hourly Urine output, 8th hourly renal parameters and daily CBC, Urine 
Complete were monitored and documented. Patients were classified into 4 
groups – NO AKI, AKIN 1, AKIN 2, AKIN 3.  
    Management was done with adequate IV Fluids, Inj.ASV, Dialysis and 
treatment of local parts. 
     All have been documented with a proforma for this study. 
Observations and results were analysed. Incidence of acute kidney injury 
in my study is 44 %. 57% are in stage 3 AKIN and most of them required 
dialysis. Few became Dialysis Dependant due to Cortical necrosis, most of 
them are known case of Hypertension. 
      Case fatality rate in our study is 4 %. All developed stage 3 AKIN. 
Death was due to complications of Acute Kidney Injury like Acidosis and 
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one patient died of severe coagulopathy- Intracerebralhaemorrhage. 
      Early admission into the hospital and administration of Inj.ASV and 
adequate hydration ,monitoring of renal parameters and coagulation 
profile by Simple bedside 20mins WBCT may prevent avoidable 
morbidity and mortality in Healthy, Young Population due to snake bite 
Envenomation. 
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PROSPECTIVE STUDY OF INCIDENCE, CLINICAL PROFILE 
&OUTCOME OF ACUTE KIDNEY INJURY IN PATIENTS WITH SNAKE 
BITE ENVENOMATION  ADMITTED IN GMKMCH 
PROFORMA 
Name:                                                                               IP. No:          Reg.No  : 
Age/sex:                                                                          Address: 
D.O.A:D.O.D: 
DA T E  &  T I M E O F  B I T E  
 
DA T E  &  T I M E O F  
A DM I S S IO N 
DEL A Y  I N  A DM I SS I O N  
( H OU RS )  
T O UR N I QU ET  A PPL I ED  
YES  /  N O 
S N A K E  I DEN T I F I ED  
YES  /  N O 
I F  YES  
 V I PER  /  CO BR A  /  
K R A I T  /  O T H ERS  
 
COMPLAINTS OF THE PATIENT: 
1.Pain  at the bite site               :  Yes / No                           
2. Bleeding from bite mark       : Yes / No                           
3. Vomiting                                  : Yes / No                           
PAST HISTORY :H/ O DM / HTN / SEIZURE DISORDER / COPD/ CAD / OTHERS 
PERSONAL HISTORY : 
DIET : Vegetarian / Non- Vegetarian / Mixed Diet 
Smoking :Alcoholism : 
TREATMENT HISTORY : 
Duration of treatment : 
No. Of vials Inj. ASV administered : 
Clotting time on Referral : 
CLINICAL FEATURES  
VITAL SIGNS  AT THE TIME OF ADMISSION 
BP PULSE RATE RESPIRATORY 
RATE 
TEMPERATURE 
    
 
SIGNS OF TOXICITY  
SIGNS DAY 1 DAY 2 DAY 3 DAY 4 DAY 5 TILL 
DISCHARGE 
VITAL SIGNS 
BP 
PULSE RATE 
      
CELLULITIS       
150 
 
REGIONAL 
LYMPHADENOPATHY 
      
CLOTTING TIME       
PTOSIS       
RESPIRATORY 
PARALYSIS 
      
SIGNS OF DIC       
 
SYSTEMIC EXAMINATION: 
1. Cardiovascular System        : 
2.Respiratory system               : 
3. Per Abdomen                        : 
4. Central Nervous System      : 
 
INVESTIGATIONS : 
USG  KUB                                    : 
OTHER INVESTIGATIONS (IF NEEDED) : 
PARAMETERS DAY 1 DAY 2 DAY 3 DAY 4 DAY 5 TILL 
DISCHARGE 
B. UREA       
SERUM 
CREATININE 
      
INPUT 
OUTPUT(Hrly) 
      
HB 
PLATELET 
COUNT 
PCV 
      
URINE 
ANALYSIS 
PROTEIN 
OTHERS 
      
NO. OF VIALS 
INJ.ASV 
ADMINISTERED 
      
ALLERGIC 
REACTIONS TO 
INJ.ASV 
      
TREATMENT: 
1.CONSERVATIVE 
      
2.PERITONEAL 
DIALYSIS 
      
3.HEMODIALYSIS       
 
FINAL INFERENCE: SNAKE BITE WITH .................................. TOXICITY WITH/ 
WITHOUT ACUTE KIDNEY INJURY (AKIN STAGE...........) MANAGED  
WTH................................... 
 
 
PATIENT CONSENT FORM 
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STUDY TITLE:   
“STUDY ON VITAMIN B12 DEFICIENCY IN CHRONIC 
METFORMIN THERAPY IN TYPE 2 DIABETES MELLITUS 
PATIENTS IN GMKMCH SALEM” 
 
DEPARTMENT OF GENERAL MEDICINE, GMKMCH, SALEM. 
 
PARTICIPANT NAME :    AGE :  SEX:   
I.P. NO : 
I confirm that I have understood the purpose of investigatory  procedure for the above 
study. I have the opportunity to ask the question and all my questions and doubts have 
been answered to my satisfaction. 
I have been explained about the possible complications that may occur during  
and after medical/ surgical procedure. I understand that my participation in the study is 
voluntary and that I am free to withdraw at any time without giving any reason. 
I understand that investigator, regulatory authorities and the ethics committee 
will not need my permission to look at my health records both in respect to the current 
study and any further research that may be conducted in relation to it, even if I 
withdraw from the study. I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required under the law. I 
agree not to restrict the use of any data or results that arise from the study. 
I hereby consent to participate in this studyfor  various investigatory 
procedures and their outcomes. 
Time : 
Date :      Signature / Thumb Impression Of Patient 
Place :       
                                                  Patient’s name: 
 
 Signature of the investigator:  ______________ 
Name of the investigator :       ______________________ 
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KEY TO MASTER CHART 
A/S Age/Sex 
SOB Site Of Bite 
BND Bite to Needle Time 
COM Co-Morbidities 
HTN Hypotension 
CEL Cellulitis 
RL Regional Lymphadenopathy 
WBCT Whole Blood Clotting Time 
RF Respiratory Failure 
ICR Initial Creatinine 
PLC Platelet Count 
AKIN Acute Kidney Injury Network 
ASV ASV Vials  
AR Allergic Reactions To ASV 
MX Management 
CM Conservative Management 
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CR Complete Recovery 
DD Dialysis Dependant 
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MASTER CHART 
Sl
. N
o.
 
N
AM
E 
   
 A
/S
 
A
D
D
RE
SS
 
SO
B 
BN
T 
CO
M
 
H
TN
 
CE
L 
RL
 
W
BC
T 
PT
O
SI
S 
RF
 
IC
R 
O
U
TP
U
T 
PL
C 
PR
O
TE
N
U
RI
A 
A
KI
N
  
N
O
 O
F 
A
SV
 
A
R 
M
X 
O
U
TC
O
M
E 
1 Kuppayee 
   
65/F Thiruchencode Lt hand 1 hr No No Yes No 
> 
20 No No 2 
non-
oliguric 160000 Trace 1 24 No CM CR 
2 Murugesan 
 
45/M Attur rt foot 2 hrs No Yes No No >20 No No 2 
non-
oliguric 240000 Nil 0 16 Yes CM CR 
3 Lakshmi 65/F Erode Rt hand 1 hr No No Yes No 
> 
20 No No 5 oliguric 100000 Trace 3 16 No Dialysis DD 
155 
 
4 Muthuramalingam 54/M Rasipuram Lt foot 12 hrs No No Yes Yes 
> 
20 No No 1 
non-
oliguric 195000 Nil 1 16 No CM CR 
5 Chinnapillai 50/F Omalur Rt ankle 8 hrs No No No No 
> 
20 No No 1 
non-
oliguric 210000 Nil 0 8 No CM CR 
6 Kuppusamy 70/M Valapadi Lt ankle 11/2hr  No No NO NO >20 No No 1 
non-
oliguric 205000 Nil 0 8 No CM CR 
7 Amutha 20/F Omalur Lt ankle 5 hrs No No Yes No 
> 
20 No No 1 
non-
oliguric 210000 Nil 3 8 No CM CR 
8 Raman 25/M Attur Rt foot 7 days No No No No 
< 
20 No No 3 
non-
oliguric 80000 Trace 3 5 No CM CR 
9 Periyasamy 65/M Chinnasalem Lt foot 4 1/2hrs  No No Yes Yes 
> 
20 No No 1 
non-
oliguric 55000 Trace 3 30 No CM CR 
10 Siddan 70/M Nangavalli Rt foot 3 hrs No No No No >20 No No 1 
non-
oliguric 212000 Nil 0 5 No CM CR 
11 Patchiyammal 37/F Attur Lt big toe 1 hr 30 mins No No No No 
> 
20 No No 1 
non-
oliguric 245000 Nil 0 21 No CM CR 
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12 Ravi 37/M Attur Rt ankle 1hr 45 mins No No Yes Yes 
> 
20 Yes No 1 
non-
oliguric 215000 Nil 0 24 No CM CR 
13 Namagiriyammal 70/M Namakkal Lt foot 2 hrs No No Yes No 
> 
20 No No 2 
non-
oliguric 180000 Trace 3 18 No CM CR 
14 Saroja 50/F Salem Lt foot 50 mins SHT No No No >20 No No 1 
non-
oliguric 210000 1+ 0 8 No CM CR 
15 Backiyam 53/F Valapadi Lt foot 13 hrs No No Yes Yes 
> 
20 No No 2 oliguric 15000 3+ 2 8 Yes Dialysis CR 
16 Jeya Prakash 40/M Namakkal Rt foot 8 hrs 15 mins PLHA No Yes No 
> 
20 No No 2 
non-
oliguric 30000 2+ 2 16 No CM CR 
17 Sundar 37/M Vedakuthapatti Lt foot 
10 hrs 40 
mins SHT No No No >20 No No 1 
non-
oliguric 240000 Nil 0 8 No CM CR 
18 Senkodan 50/M Namakkal Lt foot 30 mins No No No No 
> 
20 No No 1 
non-
oliguric 240000 Nil 0 16 No CM CR 
19 Esther Divya 21/F Erode Rt foot 4 hrs No No Yes Yes 
< 
20 No No 1 
non-
oliguric 82000 3+ 1 30 No CM CR 
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20 Saravanan 21/M Salem Rt hand 2 hrs No No No No >20 No No 1 
non-
oliguric 240000 Nil 0 8 No CM CR 
21 Ramalingam 27/M Salem Rt ankle 50 mins No No No No >20 No No 1 
non-
oliguric 240000 Nil 0 8 No CM CR 
22 Kannammal 70/F Rasipuram Lt hand 1 hr 40 mins 
SHT/ 
DM No Yes Yes 
< 
20 No No 4 
non-
oliguric 70000 3+ 3 15 No CM CR 
23 Manikodi 38/F Salem rt foot 2 hrs No No No No 
> 
20 No No 1 
non-
oliguric 240000 Nil 0 13 No CM CR 
24 Sarasu 55/F Namakkal Lt foot 2 hrs 45 mins No No Yes No 
< 
20 Yes Yes 1 
non-
oliguric 225000 1+ 0 24 No MV DEATH 
25 Ramayee 27/F Omalur Rt foot 1 hr 45 mins No No Yes Yes 
> 
20 Yes No 1 
non-
oliguric 270000 1+ 1 30 No CM CR 
26 Kannappan 55/M Rasipuram Lt foot 2 hr No No Yes Yes 
> 
20 No No 2 
non-
oliguric 60000 Nil 2 13 No CM CR 
27 Sekar 36/M Namakkal Lt foot 1 hr No No Yes Yes 
> 
20 No No 1 
non-
oliguric 310000 Nil 1 16 Yes CM CR 
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28 Palaniyammal 55/ F Attur Rt hand 1 hr  No No Yes No 
> 
20 No No 1 
non-
oliguric 410000 Nil 0 16 No CM CR 
29 Nithya 22/F Omalur Rt hand 1 hr No No No No >20 No No 1 
non-
oliguric 280000 Nil 0 5 No CM CR 
30 Marappan 50/M Salem Lt hand 2 hrs 25 mins No No No No >20 No No 1 
non-
oliguric 310000 Nil 0 5 No CM CR 
31 Mani 50/M Salem Rt foot 4 hrs 30 mins No No Yes Yes 
< 
20 No No 1 
non-
oliguric 350000 Nil 0 21 No CM CR 
32 Sujatha 32/F Salem Rt shoulder 30 mins No No No No 
> 
20 No No 1 
non-
oliguric 215000 Nil 1 16 No CM CR 
33 Rajammal  60/F Erode Lt foot 1 hr SHT No Yes Yes 
> 
20 No No 3 oliguric 30000 2+ 3 30 No Dialysis DD 
34 Ramasamy 60/M Rasipuram Rt foot 8 HRS No No yes Yes 
> 
20 no no 3 
non-
oliguric 145000 Nil 3 16 No CM CR 
35 Velu 50/M Chinnasalem Rt foot 2 HRS No No Yes Yes 
> 
20 No No 1 
non-
oliguric 190000 Nil 0 21 No CM CR 
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36 Palanisamy 25/M Salem Lt foot 30 mins No No Yes Yes >20 Yes No 1 
non-
oliguric 260000 Nil 0 13 No CM CR 
37 Thangam 40/F Krishnagiri Lt foot 12 HRS No No Yes Yes 
< 
20 No No 1 
non-
oliguric 260000 Nil 2 21 No CM CR 
38 Murugesan 45/M Namakkal Lt foot 12 HRS No No Yes Yes 
< 
20 No No 2 oliguric 30000 1+ 3 32 No Dialysis CR 
39 Govindharaj 40/M Attur Rt foot 
3HRS 30 
MINS No No Yes Yes 
> 
20 No No 1 
non-
oliguric 380000 Nil 0 13 No CM CR 
40 Vijayakumar 34/M Salem Lt hand 2 hrs 30 mins No No Yes No 
< 
20 No No 1 
non-
oliguric 160000 Nil 0 5 No CM CR 
41 Pappathi 50/F Salem Rt hand 1 hr No No Yes No 
< 
20 No No 1 
non-
oliguric 210000 Nil 0 5 No CM CR 
42 Valliammal 35/F Erode Lt foot 2 hrs No No Yes Yes 
> 
20 No No 1 
non-
oliguric 280000 Nil 0 21 No CM CR 
43 Saraswathi 40/F Rasipuram Lt foot 2 hrs No No Yes No 
< 
20 No No 1 
non-
oliguric 240000 Nil 0 5 No CM CR 
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44 Nallathambi 61/M Omalur Rt foot 1 HR No No Yes Yes 
> 
20  No No 1 
non-
oliguric 160000 Nil 0 21 No CM CR 
45 Kannan 46/F Chinnasalem Lt foot 3 hrs No No Yes Yes 
> 
20 Yes No 1 
non-
oliguric 160000 Nil 0 23 No CM CR 
46 Chinnaiyan 52/M Attur Rt foot 56 mins No No Yes Yes 
> 
20 No No 1 oliguric 20000 3+ 3 18 No CM CR 
47 Arayee 53/F Mettur Lt foot 2 HRS No No Yes Yes 
< 
20 No No 1 
non-
oliguric 350000 Nil 0 5 No CM CR 
48 Soundarya 18/F Salem Rt foot 1 HR No No Yes Yes 
> 
20 Yes No 1 
non-
oliguric 210000 Nil 0 13 No CM CR 
49 Govindhan 55/M Omalur Lt foot 2 HRS No No Yes Yes 
> 
20 Yes No 1 
non-
oliguric 210000 Nil 0 33 No CM CR 
50 vadivel 56/m attur rt foot 8 hrs no yes yes yes >20 no no 2 oliguric 50000 3+ 3 28 no dialysis CR 
51 gandhiammal 80/f rasipuram rt foot 1 hr no no Yes no <20 yes yes 1 
non-
oliguric 150000 nil 0 20 No CM CR 
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52 Elavarasan 30/F Attur Rt foot 2.30 Hrs No NO YES YES >20 NO NO 2 oliguric 50000 3+ 3 32 No CM DEATH 
53 KUMARESAN 25/M ATTUR RT FOOT 2.30 HRS NO NO YES YES >20 YES NO 1 
non-
oliguric 80000 3+ 2 30 NO CM CR 
54 KANDHASAMY 60/M KALLAKURICHI LT FOOT 2 HRS NO NO YES YES >20 NO NO 5 oliguric 40000 3+ 3 28 NO Dialysis DEATH 
55 MUTHUSAMY 20/M SALEM 
RT 
SHOULDER 2 HRS NO NO NO NO >20 NO NO 1 
non-
oliguric 180000 Nil 0 10 NO CM CR 
56 MEENA 17/F Rasipuram RT FOOT 1/2 HRS NO NO YES YES >20 NO NO 1 
non-
oliguric 280000 NIL 0 21 No CM CR 
57 GOVINDHARAJ 50/F Salem RT FOOT 2 HRS NO No Yes NO <20 NO NO 1 
non-
oliguric 210000 Nil 0 5 NO CM CR 
58 VENKATACHALAM 29/F SALEM RT HAND 7 HRS NO NO NO Yes <20 NO NO 1 
non-
oliguric 240000 NIL 0 5 NO CM CR 
59 GANABATHI 63/M SALEM RT FOOT 11/2 HRS No No YES YES >20 NO NO 2 
non-
oliguric 160000 Trace 1 23 NO CM CR 
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60 SIVAKUMAR 25/M KALLAKURICHI RT FOOT 2 HRS NO NO YES YES <20 NO NO 2 
non-
oliguric 20000 3+ 2 25 No CM CR 
61 ARUKKANI 65/F Rasipuram Lt foot 1 HR SHT NO Yes Yes >20 NO NO 1 
non-
oliguric 210000 Nil 0 8 No CM CR 
62 PERUMAYEE 60/F Salem LT FOOT 1 HR NO NO NO NO >20 NO NO 1 
non-
oliguric 150000 Nil 0 8 No CM CR 
63 NATARAJAN 65/M Valapadi RT FOOT 1 HR NO NO Yes NO <20 NO No 1 
non-
oliguric 210000 Nil 0 5 No CMC CR 
64 MENAKA 35/F OMALUR RT LEG 6 HRS No No Yes No >20 Yes NO 1 
non-
oliguric 250000 Nil 0 20 NO CM CR 
65 RAMESH 32/M DHARMAPURI RT HAND 2 HRS NO NO YES NO >20 NO NO 2 
non-
oliguric 30000 3+ 3 28 No Dialysis CR 
66 SARASWATHY 52/F Rasipuram LT FOOT 1 HR SHT NO No No >20 No No 2 oliguric 200000 3+ 3 30 NO Dialysis DD 
67 VENKATACHALAM 35/M Valapadi rt foot 1 HR NO NO Yes YES >20 No No 1 
non-
oliguric 420000 NIL 0 16 No CM CR 
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68 MANIVANNAN 20/M TIRUPUR LT FOOT  3 HRS No No Yes No >20 Yes Yes 1 
non-
oliguric 150000 Nil 0 25 No CM CR 
69 ANANDHAN 60/M Rasipuram RT LEG 1 HR No Yes Yes Yes >20 Yes No 3 oliguric 49000 1+ 3 23 No Dialysis DEATH 
70 PERUMAL 24/m Salem rt hand 4 hrs No No Yes Yes >20 No No 2 
non-
oliguric 250000 Nil 1 23 No CM CR 
71 selvi 15/f Rasipuram rt foot 2 hrs No No Yes No <20 Yes Yes 1 
non-
oliguric 230000 Nil 0 24 No MV DEATH 
72 padmavathy 55/F Salem RT FOOT  58 HRS SHT No YES NO <20 No No 4 oliguric 20000 3+ 3 8 No Dialysis DD 
73 JAYAPRADHA 46/F Salem LT HAND 1 HR No No Yes No <20 No No 1 
non-
oliguric 240000 Nil 0 5 No CM CR 
74 GURUSAMY 50/M Erode LT FOOT 1 HR No No Yes Yes <20 No No 1 
non-
oliguric 150000 Nil 1 23 No CM CR 
75 PALANIYAPPAN 52/M Salem RT FOOT 1 1/2 HRS No No Yes Yes >20 No No 3 
non-
oliguric 60000 4+ 3 28 No CM CR 
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76 PARASURAMAN 34/M NAMAKKAL RT FOOT 6 HRS NO NO YES YES >20 NO NO 1 oliguric 75000 1+ 3 36 NO Dialysis CR 
77 SARAVANAN 39/M Salem RT FOOT 51/2 HRS NO NO YES YES >20 YES NO 1 
non-
oliguric 220000 Nil 0 30 No CM CR 
78 VENNILA 44/M Salem LT FOOT 1HR NO NO NO NO >20 No NO 1 
non-
oliguric 300000 Nil 0 5 No CM CR 
79 TAMILSELVAN 29/M Rasipuram Rt hand 3 HRS No No Yes Yes >20 No No 1 
non-
oliguric 100000 1+ 1 13 No CM CR 
80 VIGNESH 21/M Salem RT FOOT 81/2 HRS NO No Yes Yes >20 No No 1 
non-
oliguric 140000 Nil 0 30 No CM CR 
81 YASOTHA 70/F Salem Rt ankle 51/2 HRS HTN NO YES YES >20 NO NO 1 oliguric 190000 2+ 3 28 No Dialysis DD 
82 BABU 30/M Salem Rt hand 4 HRS No No Yes Yes >20 No No 1 oliguric 110000 3+ 3 28 No Dialysis CR 
83 SAROJA 57/F Valapadi RT FOOT 2 HRS No No No NO >20 No No 1 
non-
oliguric 190000 0 0 5 No CM CR 
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84 RASIKA 17/F Salem RT FOOT 2 HRS No No No No >20 Yes No 1 
non-
oliguric 160000 Nil 0 5 No CM CR 
85 VAITHY GOUNDAR 25/M SANKAGIRI RT FOOT 10 1/2 HRS No No Yes Yes >20 No No 3 oliguric 60000 3+ 3 28 No Dialysis DD 
86 NAKESH 21/M DHARMAPURI LT FOOT 2 HRS No No Yes Yes >20 No No 3 oliguric 70000 2+ 3 32 No Dialysis CR 
87 Murugesan 40/M Salem RT LEG 21/2 HRS No No Yes Yes >20 No No ``2.1 oliguric 125000 1+ 2 30 NO Dialysis CR 
88 BANUPRIYA 21/F Salem RT FOOT 2 HRS No No Yes Yes <20 Yes Yes 1 
non-
oliguric 250000 0 0 20 No MV CR 
89 VYUVARAJ 17/M Salem RT LEG 1 HR No No Yes No >20 No No 1 
non-
oliguric 280000 0 0 5 No CM CR 
90 SAHANKAR 29/M DHARMAPURI RT LEG 1 HRS No No Yes Yes >20 No No 1 
non-
oliguric 170000 Trace 0 30 No CM CR 
91 GANABATHI 63/M KALLAKURICHI RT FOOT 1/2 HRS No No Yes No >20 No No 1 
non-
oliguric 220000 Nil 0 33 No CM CR 
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92 GANAGAMALAI 42/F Namakkal RT LEG 31/2 HRS No No Yes No >20 No No 1 
non-
oliguric 370000 Nil 0 15 No CM CR 
93 THANGAMALAI 52/F Omalur Rt ankle 11/2 HRS No No Yes Yes >20 No No 1 oliguric 15000 3+ 3 30 No Dialysis DD 
94 PREMKUMAR 19/M Mettur LT FOOT 2 HRS No No Yes Yes >20 No No 1 
non-
oliguric 120000 0 0 20 No CM CR 
95 Raja  38/M Rasipuram RT HAND 21/2 HRS No No Yes Yes >20 No No 1 
non-
oliguric 190000 0 0   No CM CR 
96 KARAN 16/M MECHERY RT FOOT 3 HRS No No Yes Yes >20 No No 1 
non-
oliguric 160000 0 0 20 No CM CR 
97 ESHWARI 24/F SALEM RT FOOT 21/2 HRS No No No No >20 No No 1 
non-
oliguric 190000 0 0 5 No CM CR 
98 MEENA 18/F Salem RT FOOT 21/2 HRS No No Yes No <20 No No 1 
non-
oliguric 180000 0 0 5 No CM CR 
99 BOOPATHY 70/M Salem RT FOOT 33 HRS No No Yes Yes >20 No No 5 oliguric 20000 3+ 3 30 No Dialysis DEATH 
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100 RAMASAMY 47/M MECHERY RT LEG 21/2 HRS No No Yes Yes >20 No No 1 
non-
oliguric 260000 1+ 1 33 No CM CR 
